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1. Introduction
1.1. The zebrafish model to study the gene function
The zebrafish (Danio rerio, D. rerio) constitutes a prominent model
vertebrate to study gene function and model numerous human diseases
(Ablain and Zon, 2013). Compared to rodent models, it shows particular
advantages in personalized medicine (Baxendale et al., 2017) and
High-throughput (HTP) studies (MacRae and Peterson, 2015).
The full annotation of the Tübingen strain zebrafish genome (Howe et al.,
2013) unveiled that 70 % of the human genes have an orthologue in
zebrafish; a percentage that raises to 82 % when considering only
disease-associated genes (Howe et al., 2013). Not only individual genes,
but several molecular processes and organ functions are conserved
between fish and humans (Griffin et al., 2018). Beside its genetic and
histological similarity to mammals, zebrafish offers a series of unique
advantages, that makes it an amenable choice in studies that require
high sample numbers or refined characterization of intracellular
molecular dynamics. Compared to mammalian models, zebrafish are
cheap to maintain, small in size, and characterized by a large number of
progeny, therefore suitable for HTP screening and toxicology studies of
small molecules and biologics. As 90 % of new drugs under clinical
development fail to be approved by the FDA (in 83 % of the cases
because of issues with efficacy or safety) (Hay et al., 2014), the
zebrafish model may provide large datasets on these critical parameters
quickly and directly in the in vivo context. Pharma companies leading the
field of drug development decided to adopt this animal model “..to study
the effects of compounds on target organ toxicities” prior clinical trials
(technical note by Roche).
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Additionally, zebrafish is unique among vertebrate animal models for the
almost complete transparency of the embryo and the quick development
outside the mothers body. These features permit to perform single cell
resolution in vivo imaging starting from the very first developmental
stages. Easy generation of transgenic lines with tissue- and cell- specific
mutations further facilitate gene function studies with high spatial and
temporal resolution. When using pigmentation mutants, as Nacre,
Casper or Crystal (White et al., 2008; Antinucci et al., 2016), these
advantages can be even partially maintained also in adult samples.
The advent of modern genome editing techniques, together with the
external fertilization and development of the zebrafish, made this
organism model extremely easy to be modified on the genetic level
(Sassen and Köster, 2015). Originally, mutant fish lines were created to
study the function of genes involved in embryonic development (see
paragraph 1.1.1). Shortly afterwards scientists started to model human
diseases in zebrafish for studying the molecular mechanisms that
underline pathogenesis (Ceol et al., 2011; Berger and Currie, 2012). In
2015, a drug discovered in zebrafish entered the clinical trials (Cutler et
al., 2013) and recently a new hope for epileptic patients resistant to
available anti-epileptic drugs (AEDs) may arise from studies conducted
in mutant fish modeling this disease (Griffin et al., 2017; Baraban et al.,
2013).
The application of zebrafish in cancer biology deserves particular
attention. From 2005 to nowadays, several zebrafish tumor lines have
been generated and validated to model different human cancers
(Amsterdam et al., 2004; Patton et al., 2005; Liu and Leach, 2011; Jung
et al., 2013; Ju et al., 2015; Nguyen et al., 2016; Phelps et al., 2016;
Anelli et al., 2017), but the main strength of zebrafish for cancer
research remain the ease of generation of tumor xenograft models
(Zhang et al., 2015; Moore and Langenau, 2016).
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Furthermore in zebrafish, but not in mouse, it is possible to create
patient-derived cancer cell xenografts for individualized prognosis and
patient-tailored therapy (Marques et al., 2009; Welker et al., 2016;
Mercatali et al., 2016; Au et al., 2016).
In conclusion, zebrafish is a reference animal model to unveil gene
function and to allow for phenotype based screening of drugs on a fully
integrated vertebrate organ systems (MacRae and Peterson, 2015;
Rennekamp and Peterson, 2015; Wiley et al., 2017). Recently, the
zebrafish model started to assume an additional pivotal role in
personalized medicine thanks to its ease of manipulation (Baxendale al.
2017).
1.1.1. Zebrafish gene knockout technologies and limitations
Specific pathological human conditions can be reproduced or studied in
organism models abolishing the expression of certain genes. When
knocking out a gene in vivo, it is possible to infer its role from the effect
produced by its absence at molecular, cellular, or systemic level.
Different approaches have been developed over the time to inhibit gene
expression and they go under two main categories: forward genetics
and reverse genetics.
In forward genetic approaches, randomly mutagenized animals showing
an abnormal phenotype are selected and the mutated genes identified.
In reverse genetic approaches, known genes are disrupted and the
consequent phenotype analyzed. Forward genetics approaches in
zebrafish were initially based on the use of radiation as mutagenic agent
(Walker and Streisinger, 1983), which was quickly replaced by the more
efficacious chemical compound N-ethyl-N-nitrosourea (ENU) for large
scale mutagenesis projects. Examples of successful large scale
mutagenesis campaigns are the Tübingen and Boston screening
projects (Haffter et al., 1996; van Eeden et al., 1996; Nusslein-Volhard,
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2012), or the Zebrafish Mutation Project (Kettleborough et al., 2013).
With these screening projects were introduced mutations in more than
12,000 genes, accounting for ca. 45 % of zebrafish protein-coding genes
(Howe et al., 2013). Alternatively to chemical mutagenesis, insertional
mutagenesis screen were used to generate large libraries of zebrafish
mutants (Gaiano et al., 1996; Amsterdam et al., 1999; Golling et al.,
2002; Amsterdam et al., 2004). Mutagenesis screening campaigns were
aimed to discover developmental mutants. Indeed, with these
approaches the first gene function (timewise) is the one to be revealed.
This aspect, and the presence of post-embryonic lethal mutations,
introduces a bias towards the discovery of mutations, which affect fish
development. While ENU mutagenesis allows for quickly generating
many mutants within very short time, the following work to map the
mutations with positional cloning techniques is time consuming and
laborious. The presence of genome duplication in teleostei fish, like
zebrafish, further increased these difficulties, so that for several mutants
could not be characterized (labeled as “ambiguous” location or
unspecified function in ZFIN database). Differently from chemically
mutated genes, those mutated via viral insertion are easy to clone,
aspect which significantly speeds up the process of mutation
identification.
Despite the enormous contribution of these large mutagenesis screens,
the availability of a fully annotated zebrafish genome since 2010 (Howe
et al., 2013), and the generation of new genome editing technologies
opened the way to the gradual shift towards targeted mutagenesis
approaches and the zebrafish era of reverse genetic. Targeted
mutagenesis became available for the zebrafish community in 2008,
when Xiangdong Meng and Yannick Doyon independently published
(Meng et al., 2008; Doyon et al., 2008) the generation of the first
heritable and targeted approach for gene knockout in zebrafish using
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engineered zinc finger nucleases (ZFNs). ZFNs are fusions of a
Cys2His2 zinc finger protein providing DNA binding to a FokI
endonuclease providing cleavage activity. In the dimeric state, they
introduce double-stranded breaks into the targeted gene sequence. The
capability to introduce mutations is not intrinsic of the technique, but is
based on the error-prone repair mechanism of the non-homologous end
joining (NHEJ) pathway. The applicability of this technique is drastically
limited by the laborious and expensive engineering of the ZFN to reach
the desired target specificity, which remains context dependent and
therefore unpredictable (Ramirez et al., 2008). Also, ZFNs cannot be
applied universally due to the limited number of existing ZF modules
(Sander et al., 2011). A system similar to ZFNs was introduced in 2012
by Bedell V. and colleagues (Bedell et al., 2012) based on the use of
modular single nucleotide DNA-binding domains (DBDs). DBDs are
derived from Transcription Activator-Like Effector (TALE) domains and
when fused to FokI endonucleases form TALENs. TALENs DBDs are
easier to design, not restricted to existing sequence specificities and not
context dependent (Li, 2011). TALENs dimers need to recognize
adjacent DNA sequences to introduce a double-stranded break in
between, meaning that no monomer-mediated cleavage can occur, a
condition that limits unwanted off-targeting. Up to date, TALENs based
mutagenesis is still considered to provide very high specificity. Despite
these techniques revolutionized the way to do reverse genetic in
zebrafish, both are methylation sensitive and limited by the need of de
novo probe design, synthesis, and in vitro specificity tests per each
different gene target. Furthermore, the in vitro tests are not fully
predictive of in vivo activity. These limitations were eliminated by the
game-changing CRISPR/Cas9 based mutagenesis approach (Hwang et
al., 2013; Li et al., 2016). The Cas9 DNA cleavage activity is
RNA-directed, erasing the need for generating a DBD specific for each
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target and limiting the de novo design to the in silico single guide RNA
(sgRNA) design. The endonuclease Cas9 mRNA synthesized in vitro is
co-injected with the sgRNA into the zebrafish embryo. Alternatively to
the Cas9 mRNA, the purified protein can be directly co-injected with the
sgRNA. This eliminates the lag introduced by the translation time
required when injecting Cas9 mRNA. Also, direct GFP-fusion to Cas9
allows for direct screening of positively injected embryos. Cas9 cleaves
double-stranded DNA introducing a double strand break (DSB) at a
specific site. This DSB will be repaired by the host cellular
Non-Homologous End Joining (NHEJ) repair mechanism, which
introduces indels resulting in the target gene disruption. Alternatively,
this technique can also be used to replace a gene or part of it, by
homologous recombination, when co-injecting the new DNA strand in
addition. In this way it is possible to knockout a gene introducing in its
sequence a targeted mutation, or a deletion, this time using the
Homology directed repair (HDR) mechanism. The fast and cheap design
allows for testing in parallel different sgRNAs to mutate the same gene
and afterwards verify that all the induced null mutant phenotypes are
identical and not complementary. Many human diseases are associated
to partial, and not complete, loss of protein activity. Also, it has to be
noticed that ca. 30 % of genetic knockout are embryonically lethal in
mouse (Dickerson et al., 2011) and that this technology does not permit
to independently analyze different protein isoforms originating from the
same gene. In these cases, gene knockout approaches are not
applicable.
1.1.2. Zebrafish gene knockdown technologies and limitations
Together with gene knockout approaches, gene silencing (or gene
knockdown) constitutes the most diffuse approach to study the function
of a gene. Contrarily to gene knockout, where null mutations at DNA
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level prevent the formation of the full-length gene transcript, in case of
gene knockdown, mRNA translation is prevented in the cytosolic
compartment by antisense morpholino-modified oligonucleotides
(morpholinos) or double strand RNA (RNA interference; RNAi). These
probes anneal to the target gene transcript, leading to translation
repression and mRNA degradation. Their effect lasts for a few days
because of short term degradation and it is suitable to study on the first
function of a gene (timewise).
Morpholinos mediated knockdown in zebrafish was introduced in 2000
by Nasevicius and colleagues (Nasevicius and Ekker, 2000) and widely
used until the scientific community realized the high risk of off-targeting
associated to the use of antisense oligonucleotides (Place et al., 2017;
Boer et al., 2016; Eve et al., 2017). One of the major cause of the
off-targeting effects induced by morpholinos is the unspecific induction
of p53-dependent apoptosis (Pickart et al., 2006; Robu et al., 2007;
Gerety et al., 2011). Despite the fact that numerous appropriate controls
can help to correctly interpret results generated with morpholinos (Bedell
et al., 2011), the drawbacks of using this technology are not negligible.
RNA interference approaches do not induce the p53 pathway.
Nevertheless, many cases reported that this approach is not highly
specific for the intended target (Jackson et al., 2003; Jackson et al.,
2004; Persengiev et al., 2004; Kulkarni et al., 2006; Ma et al., 2006;
Echeverri et al., 2006; Dietzl et al., 2007; Seok et al., 2018). Beside
unspecific targeting, RNAi has been shown to induce an unwanted
interferon response, also dependent on the probe length (Bridge et al.,
2003; Pebernard et al., 2004; Sledz et al., 2003). An other limitation
when using RNAi, or morpholinos, is the absence of a straightforward
and systematic specificity assessment.
The rescue of the induced phenotype via expressing an homologous
gene from a different species or RNAi-resistant DNA (Kittler et al., 2005;
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Langer et al., 2010; Sigoillot and Randall 2011) constitutes the only,
even if valuable, option. Indirect prove of the knockdown specificity can
be obtained comparing the knockdown phenotype to the phenotype
generated via knockout of the same gene target.
This second, time consuming and laborious approach, is also risky since
the effect of knockout and knockdown for the same gene are not
necessarily overlapping (see paragraph 1.1.3).
Recently the CRISPR approach has been (Rousseauet al., 2018)
adapted to introduce specific cleavage in RNA sequences (CRISPR
interference, CRISPRi). So far this approach has been tested only in
vitro, and it showed to have reduced off-target effects, but also showed a
strong clonal effect.
1.1.3. Controversial mutant phenotypes
Over the past years, the zebrafish community encountered increasing
difficulties in recapitulating mutant phenotypes with morpholino induced
phenotypes (Kok et al., 2015; Novodvorsky et al., 2015). Accordingly, a
comparison of published morpholino induced phenotypes with mutant
phenotypes from the Zebrafish Mutation Project data (Kettleborough et
al., 2013) indicated that circa 80 % of morphant phenotypes are not
observed in mutant embryos (Kok et al., 2015). What was supposed to
be an approach to certify mutant phenotype specificity became
argument of concern in respect of both, gene knockout as well as gene
knockdown technologies.
This discrepancy may be explained considering the off-targeting effects
induced by antisense oligonucleotides, RNAi and CRISPRi. A systematic
comparison (Stojic et al., 2018) of these three techniques proved the
induced phenotype was different in the three cases, as different were the
off-target genes expressed. On the other side, very often knockout
mutants do not show any overt phenotype because of genetic
Introduction
9
compensation (Rossi et al., 2015), or incomplete loss of function
(Anderson et al., 2017). Anderson and colleagues proved how
alternative splicing and splice sites, ribosomal frameshifting, or
nonsense readthrough in zebrafish, can lead to genotypically null
mutants with wild type phenotype, even for mutations introduced in
essential genes. Similar findings emerged also when looking at the
human genome of healthy subjects (Sulem et al., 2015; Chen et al.,
2016; Narasimhan et al., 2016; Jagannathan et al., 2016).
Understanding the underlying compensatory mechanisms is a new and
ongoing field of research and does not yet allow one to completely
explain or avoid these phenomena (El-Brolosy and Stainier 2017), which
are consequently very hard to detect (especially when involving
nonsense readthrough).
Gene silencing and gene knockout induced phenotypes may not reflect
each other and they may be biased by unspecificity in the case of gene
silencing or cryptic compensatory mechanisms in the case of gene
knockouts. This aspects can compromise the functional analysis of
certain genes. Being aware that gene silencing and gene knockout
cannot be systematically used to crosscheck a certain phenotype, an
alternative approach is needed. This alternative should be highly specific
and avoid the limitations of classic gene knockdown and knockout
approaches. Recently emerging methods to directly interfere with the
target protein activity would provide such an alternative.
1.2. Intrabody technology
Immunoglobulins (Ig) are molecules produced by the plasma cells during
the activation of the humoral immune system in response to pathogen
invasion and cancer, or during allergic reactions and autoimmune
diseases. Because of their direct (e.g. by neutralizing) and indirect (via
an effector function) activity of target inhibition, these molecules are
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characterized by an intrinsic very high affinity and specificity towards
their target, allowing to bind to one particular antigen molecule within
highly concentrated and diverse mixtures of biomolecules, like in the
blood plasma. Like other plasma proteins, antibodies are produced
through the secretory pathway. ER oxidizing milieu, and ER resident
chaperones have been proved to be necessary for correct antibody
folding (Feige et al., 2010). In addition, correct folding of the
antigen-contacting Ig heavy chain variable domains (VH) and light chain
variable domains (VL) depends on the formation of intrachain disulfide
bonds. VH and VL can be connected by a flexible linker (Huston JS et al.,
1988) to generate a single chain fragment variable antibody fragment
(scFv). The scFv constitutes the smallest IgG-derived antibody format
that maintains the original antibody high specificity to its target. When
intracellularly expressed, an scFv can be designated as an intrabody,
and can interfere with the function of it's target protein. Intrabodies can
be produced in different cellular compartments: in the endoplasmic
reticulum (ER) where the secretory pathway starts (ER intrabody), or in
the cytosol (intracellular antibodies, ICAbs). In addition to the
significantly different groups of antigens that can be targeted in the two
cases (plasma/membrane versus cytoplasmic proteins), other intrinsic
properties differentiate these two intrabody applications, impacting their
individual benefits and ease of use.
ICAbs typically are scFv fragments expressed into the cytosol, thus their
effect on the target protein relies on some direct inhibition of target
function provided by the mere binding.
Without such inhibitory effect, ICAbs, even when highly specific and
binding with high affinity, can only be used to “label” a protein. Common
targets of ICAbs are cytosolic and nuclear proteins. The cytosolic
compartment is characterized by the presence of reducing biochemical
conditions, lacking necessary chaperones and not allowing disulfide
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bridges to form, so only very few IgGs can fold correctly in this cellular
compartment (Biocca et al., 1995; Wörn and Plückthun, 2001).
Consequently, expression of scFv antibodies in the cytosol, as such,
often results in the production of unfolded insoluble antibodies
aggregates, or soluble but non-functional scFv with short half life
(Cattaneo and Biocca, 1999). Also, antibody solubility during production
in bacterial cells (often used for antibody selection) is not predictive of
correct folding in mammalian cells, thus limiting the chances to preselect
stable ICAbs in bacteria (Guglielmi et al., 2011). Partial solution to the
natural absence of antibody folding in the cytosol is offered by the
following two alternatives: the adoption of extremely sophisticated
screening techniques designed ad hoc for ICAbs selection in the scFv
format (Biocca et al., 1994; Visintin et al., 1999, 2002), or the generation
of libraries for antibody selection in a different format than scFv. These
formats include: single domain antibodies, mainly Camelid and shark
antibodies (Philibert et al., 2007; Dong et al., 2010; Tremblay et al., 2010;
Saerens et al., 2005), cysteine-free scFv’s (Seo et al., 2009), or
antibody-like or completely different scaffolds naturally lacking disulfide
bonds (like fibronectin VIII or DARPINs) (Amstutz et al., 2005; Kohl et al.,
2005; Gross et al., 2016). Independently from individual benefits and
drawbacks, no one of the systems developed to improve functionality
after expression in the cytosol solves the need for selecting not only
highly specific and affine antibodies, but in addition those capable of
neutralizing the antigen activity upon binding.
In contrast, an ER intrabody is an scFv fused to the KDEL ER-retention
signal and reduces the protein target levels in their final destination
(membranes or plasma) via physically retaining it in the ER
compartment. The retention is mediated by the binding of the KDEL to
the ER lumen protein-retaining receptors (KDEL receptor) (Figure 1).
The retention prevents the antigenic target from reaching its active
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compartment. This way, antigen neutralization upon binding is not
required to mediated ER intrabody protein knockdown. As
ER intrabodies are made in the native compartment of their production,
they are expected to fold correctly. Consequently, no laborious and time
consuming screening techniques are required to generate
ER intrabodies. The fusions in frame to a selected scFv of the KDEL
peptide sequence (C-terminal) and of the SP (N-terminal) are the
minimal and only change necessary to constitute an ER intrabody. Circa
39 % of the human proteome is destined to the secretory pathway
(Uhlén et al., 2015) and can be therefore subjected to ER intrabody
targeting. Most common targets are proteins displayed on the cell
surface, secreted proteins, glycosyltransferases Golgi-resident, and
other endomembrane system proteins. Significantly, therapeutically
relevant targets form a large fraction among proteins of the secretory
pathway (Kuhlmann et al., 2018).
In contrast to all methods to analyze gene function by inactivation
described above, the ER intrabody approach consists in knocking down
a target at protein level, offering the unique possibility to finely
discriminate among different isoforms of a protein. Acting at protein level,
it is not influenced by genetic compensatory mechanism which affect the
efficiency of DNA or RNA based approaches. Nevertheless, it should be
considered the exponentially higher number of antigen proteins to be
addressed with intrabodies compared to DNA methods which target only
two alleles in the genome. ER intrabodies provide an alternative to
classic nucleotide based knockdown and knockout methods, crucial
when the latter fail to reciprocally recapitulate their induced phenotype.
The absence of need for target inhibition upon binding allows for using
the ER intrabody for target knockdown in a selective subcellular
compartment. Best example of this approach, is the the functional
knockdown of Sec61a in the endosomal compartment without affecting
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its natural activity in the ER compartment (Zehner et al., 2016).
Intrabody application has also been proposed for therapeutic
applications, for these diseases characterized by gene expression
upregulation, which includes infectious diseases and cancer therapy
(Kontermann, 2004; Marschall and Dübel, 2016). Recently, it has been
demonstrated to be applicable in vivo, by knocking down the VCAM1
expression levels in transgenic mice (Marschall et al., 2014).
1.2.1. ER intrabody mechanism of action
The high level of compartmentalization inside of eukaryotic cells requires
complex vesicular systems for the specific trafficking of certain lipids and
proteins from one compartment to the other. In the secretory pathway,
proteins expressed in the ER reach the Golgi apparatus in COPII-coated
vesicle (anterograde transport). In the Golgi, proteins are further sorted
for secretion, surface display, retention in the Golgi, or retrieval to the ER
compartment. Export from the ER is partially regulated and only properly
folded proteins can be targeted to the cis-Golgi and from there to the
Golgi apparatus. In the latter compartment, ER resident proteins are
recognized for the presence of a tetrapeptide motif, KDEL
(Lys-Asp-Glu-Leu) and retrotransported to the ER into COPI-coated
vesicle (retrograde transport). In humans, the receptors that mediate
KDEL binding and provide retrotransport to the ER are ERD21, ERD22,
and ERD23. All three proteins share the same function and show only
slight substrate differences (Raykhel et al., 2007), so they are commonly
referred to as KDEL receptors. They are all homologous of the yeast
Erd2, which specifically recognizes the HDEL sequence of yeast
ER-resident proteins (Semenza et al., 1990). The KDEL receptors
interact simultaneously with the cargo (KDEL) and COPI vesicle
components (Majoul et al., 2001). The KDEL binding is pH dependent,
providing binding in the Golgi and inside the COPI-coated vesicle, but
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the release in the ER lumen, since the pH in the cis-Golgi is lower (pH
6.7) than in the ER lumen (pH 7.2) (Scheel and Pelham, 1996). The
KDEL receptor retrotransport system can be found in all eukaryotes and
plants and is highly conserved. Among vertebrates in particular, the
degree of sequence similarity for the KDEL receptor is extremely high.
Between human and mouse KDEL receptor 2, the amino acid sequence
identity is 98,6 %; and for human and zebrafish 91,5 %.
As ER intrabodies are KDEL-fused scFv antibodies, they undergo the
same pathway of all the ER resident proteins. Due to the high affinity
binding to their target, they force their antigen to the same locations:
even when an ER intrabody-antigen complex escapes the ER, it is duly
retrotransported to this compartment (Figure 1). Here, it may be
degraded by the proteasome-dependent or proteasome-independent
ER-associated protein degradation (ERAD) system (Schmitz et al., 2004;
Meusser et al., 2005; Donoso et al., 2005). This ER retention
mechanism is very powerful as the KDEL receptor is capable of retaining
ca. a tenfold molar excess of protein substrate (Pelham, 1996).
Fig. 1: ER intrabody mediated knockdown schematic illustration.
Upon expression into the secretory pathway the ER intrabody binds the antigen
target inside the lumen of the ER. From this compartment the two molecules are
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transported into COPII-coated vesicle to the cis-golgi. Here, due to slight pH
acidification, the KDEL receptor (KDELR) binds the KDEL sequence of the ER
intrabody. Upon binding, KDELRs multimerize and induce the formation of
COPI-coated vesicles containing the ER intrabody - antigen complex as well.
The vesicles are retro-transported to the ER where the lower pH induces the
release of the KDEL-fused protein from the KDELR. Hence, the antigen target is
retained between the ER lumen and the cis-golgi without reaching its final
destination.
1.2.2. ER intrabody generation
The most convenient format of an ER intrabody comprises of a
polypeptide chain where an scFv fragment in fused N-terminally to a
signal peptide (SP) and C-terminally to the KDEL sequence. To fuse the
scFv gene in frame with the SP and the KDEL DNA sequences, it is
sufficient a single cloning step inserting the scFv gene into a ER
intrabody mammalian expression vector. Therefore the main effort for
the generation of an ER intrabody is to provide DNA sequences
encoding for a VH and VL antibody pair specific to the desired target.
This information can be extracted from available hybridoma clones, but
this requires careful analysis for correct function in the not infrequent
cases where more than one specificity is secreted by one hybridoma cell
(Bradbury et al., 2018).
These problems are avoided by using sequence defined antibodies from
the start, typically generated by in vitro display techniques (Breitling et
al., 1991; Bradbury et al., 2011; Hust et al., 2011) to select recombinant
monoclonal antibodies directly in the scFv format from antibody gene
libraries, through a highly customizable selection method. An antibody
gene library can be generated from any animal species, including
human, without any need for immunization (universal non-immune
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library) (Glanville et al., 2009; Schofield et al., 2007; de Wildt et al., 2000;
Hust et al., 2011; Kügler et al., 2015), but it can also be patient derived
or follow animal immunization (immune library) (Trott et al., 2014; Chan
et al.,1996). Alternatively the library can be of synthetic or semi-synthetic
origin (Tiller et al., 2013; Hoet et al., 2005). The most widely used in vitro
technology for antibody selection is antibody phage display (Breitling et
al., 1991), and the antibody selection process is named panning. The
panning procedure can be designed to reduce unwanted
cross-reactivities, to obtain cross species specific antibodies, target
post-translational modification or conformation specific antibodies
(Frenzel et al., 2017). With this approach it is possible to generate highly
specific recombinant monoclonal scFv antibodies ready to be cloned
and expressed as ER intrabodies (Zhang et al., 2012). Nowadays,
phage display for antibody selection is one standard for therapeutic
human antibody generation, and is progressively replacing animal
immunization and hybridoma technology in the generation of research
antibodies as well (Gray et al., 2016). In many cases, scFv genes for ER
intrabody generation is already available thanks to international
research efforts, like the “Affinomics” EU project (www.affinomics.org),
which provided antibodies to hundreds of different targets. The
increasing availability of recombinant monoclonal antibody sequences
(Colwill et al., 2011; Schofield et al., 2007; Sidhu 2012; Mersmann et al.,
2010; Hust et al., 2011) will drastically reduce the effort for ER intrabody
generation in the future. So, even if RNAi based knockdown approaches
remain easier and faster in respect of the reagent generation, ER
intrabody today constitute a practicable alternative, providing the
advantages of a different mechanism of action directly at the protein
level.
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1.3. Cadherin-2 (Cdh2)
Cadherins constitute a superfamily of calcium-dependent adhesion
molecules required for the formation of adherens junctions, cell
polarization, and hetero/homophilic interactions between juxtaposed
cells (Takeichi, 1991; Zhu and Luo, 2004), conducting a pivotal role in
morphogenesis and tissue repair (Gumbiner et al., 2005). Cadherin-2
(N-cadherin; Cdh2), is a type I transmembrane glycoprotein belonging to
the subfamily of classical cadherins. It is the first cadherin discovered in
the vertebrate nervous system (Hatta and Takeichi, 1986; Miyatani et al.,
1989; Redies, 2000; Yagi and Takeichi, 2000), and its function is highly
conserved among vertebrates.
Cdh2 domain structure is composed of a N-terminal propeptide, required
to avoid intracellular aggregation, an extracellular region, a
transmembrane single-pass domain, and an intracellular domain which
directly interacts with the cell cytoskeleton, mainly via ß-catenin binding.
The extracellular domain is in turn composed by five extracellular
immunoglobulin (Ig)-like domains (Cdh2-ECDs) with calcium binding
pockets interspersed at the interface between consecutive EC-domains
(Tepass et al., 2000).
1.3.1. Cdh2 expression pattern and physiologic function
Indicating a crucial role in development morphogenesis, Cdh2 is almost
ubiquitously expressed throughout the early developmental stages of
vertebrates. In the adult, its expression is restricted to specific neuronal
populations in the central nervous system (CNS), and the myocardium
(Redies et al., 1993; Redies and Takeichi, 1993). Neurodevelopmental
processes depending on Cdh2 activity include: migration of newly
synthesized neurons, axonal growth, target identification, formation of
synaptic contacts, and generally tissue architecture formation and tissue
homeostasis (Suzuki and Takeichi, 2008). Mice, or zebrafish, lacking
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Cdh2 activity, which results in loss of cell-cell adhesivity, show
compromised neural tube formation (Lele et al., 2002; Radice et al.,
1997). This primary neurulation effects induced by the absence of cdh2
expression, in turn result in impaired neuronal migration (Kawauchi et al.,
2010; Shikanai et al., 2011; Taniguchi et al., 2006; Luccardini et al., 2013;
Rieger et al., 2009). The role of Cdh2 in the cardiac muscle is essential
for cardiomyocyte mechanical coupling and differentiation
(Ferreira-Cornwell et al., 2002; Bagatto et al., 2006; Luo et al., 2001). A
role of Cdh2 in promoting cell motility has been observed in several
tumors, resulting in increased cancer invasion and metastatic behavior.
This mechanism affects also tissues that do not normally express this
molecule, and is part of a process named Epithelial–mesenchymal
transition (EMT) where tumor cells are subjected to class switch from
Cadherin-1 to Cadherin-2 (Hsu et al., 1996; Li and Herlyn, 2000;
Hirohashi, 1998; Perl et al., 1998; Nieman et al., 1999; Suyama et al.,
2002; Islam et al., 1996). The role of Cdh2 in tumor progression allows
for using this antigen as prognostic factor and potential biomarker for the
prediction of metastases.
1.3.2. Zebrafish Cdh2 knockout and knockdown phenotype
ENU-generated Cdh2 defective zebrafish mutants show loss of
neuroepithelium pseudostratification which translates in cells
delamination and aggregation, demonstrating the crucial role of Cdh2 to
guarantee the neural tube integrity and correct morphogenesis (Lele et
al., 2002). This role of Cdh2 was already documented in chicken
(Gänzler-Odenthal and Redies, 1998) and mouse (Kostetskii et al., 2001)
embryos. For all of these models, the loss of neural tube integrity can be
attributed to the loss of Cdh2 mediated cell adhesivity. Cdh2 seems also
to have a relevant role in the regulation of neuronal proliferation, as its
ablation during midsegmentation leads to hyperproliferation in the alar
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regions of the neural tube (Gänzler-Odenthal and Redies, 1998; Lele et
al., 2002), an effect which may rely on the Cdh2 mediated distribution of
ß-catenin, its intracellular partner.
In zebrafish, loss of Cdh2 further impairs neurulation, axonogenesis, and
pathfinding, convergence of alar plate, and in general restriction of
neuron motility within the neural tube, with consequent loss of
regionalization (Lele et al., 2002). The phenotypical effects found in
pacR2.10 Cdh2 zebrafish mutants were fully recapitulated by two
different Cdh2 morpholinos induced phenotypes (Lele et al., 2002). The
particular possibility to phenocopy the pacR2.10 mutant phenotype with
knockdown approaches offers the possibility to test the ER intrabody
mediated knockdown system to reproduce already described effects and
validate this technology in zebrafish for the first time.
1.4 Aim of the study
Consequently, this study aims to demonstrate for the first time the ER
intrabody knockdown technology can be successfully used in zebrafish
to interfere in cell culture and in vivo with the activity of Cadherin 2
during CNS development. This includes the initial generation of
recombinant cadherin variants as antigens, the generation of
recombinant (sequence defined) antibodies against these antigens by
phage display, their characterization and finally their application as
intrabodies in zebrafish cell culture (in vitro) and in the whole organism
(in vivo).
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2. Materials and Methods
2.1 Materials
2.1.1 Equipment
The technical equipment used in this study is listed in table 2.1.
Table 2.1: Technical equipment
Equipment Name Supplier
Analytical balance Model 1205MP
E 1200 S
Analytic A 120 S
EMB 220-1
Sartorius (Göttingen, DE)
Sartorius (Göttingen, DE)
Sartorius (Göttingen, DE)
Kern (Balingen, DE)
Blotting device Trans-Blot Turbo
Transfer
Bio-Rad (München, DE)
Centrifuge Eppendorf 5810R
Eppendorf 5804R
Eppendorf 5415D
Multifuge 3 S-R
Eppendorf (Hamburg, DE)
Eppendorf (Hamburg, DE)
Heraeus (Hanau, DE)
Confocal laser scanning
microscope
SP8 Leica microsystems
(Wetzlar, DE)
ELISA-Washer Columbus Pro
Columbus Plus
Hydrospeed
Tecan (Crailsheim, DE)
Tecan (Crailsheim, DE)
Tecan (Crailsheim, DE)
ELISA-Reader SUNRISE
Epoch
Tecan (Crailsheim, DE)
BioTek (Bad Friedrichshall,
DE)
Electroporation device Gene Pulser Xcell + CE
module
BioRad (München, DE)
Epifluorescent DM5500B Leica microsystems
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Equipment Name Supplier
microscope (Wetzlar, DE)
Flow cytometer SH-800 cell sorter
CytoFLEX
Sony (San Jose, CA, USA)
Beckman Coulter (Brea,
CA, USA)
Gel documentation Chemicoc MP Imaging
System
Bio-Rad (München, DE)
Gel electrophoresis
chamber
PerfectBlue Mini S
PerfectBlue Mini ExM
Mini-Protean 3 Cell
Peqlab (Erlangen, DE)
Peqlab (Erlangen, DE)
Bio-Rad (München, DE)
Incubator for bacterial
cells
Incubator BE400 Memmert (Schwabach,
DE)
Incubator for
mammalian cells
Heraeus HeraCell (Langenselbold,
DE)
Incubator for zebrafish
cells
Incubator I Memmert (Schwabach,
DE)
Incubator for zebrafish
embryos
B6120 Heraeus Instruments
(Hanau, DE)
Incubator shaker for
bacterial cells
Multitron standard
Certomat BS-1
VorTemp 56
Infors HT (Einsbach, DE)
Satorius (Göttingen, DE)
Labnet (Austin, USA)
Incubator shaker for
mammalian cells
Minitron Infors HT (Einsbach, DE)
Laminar flow bench for
bacteria
LaminAir HLB 2472
MSC Advantage
Thermo Scientific
(Waltham, USA)
Laminar flow bench for
mammalian cells
HeraSafe Heraeus Instruments
(Hanau, DE)
Laminar flow bench for Vertical laminar flow Bio Base, Wolfenbüttel,
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Equipment Name Supplier
zebrafish cells bench DE
Light microscope TELAVAL 31
TS100
Zeiss, Oberkochen, DE
Nikon, Dűsseldorf, DE
Microinjector Femtojet Express Eppendorf (Hamburg, DE)
Microplate shaker VorTempTM 56 Labnet-Corning (New
York, USA)
Needle puller P-87 Sutter Instrument (Novato,
CA, USA)
pH meter CG810 Schott (Mainz, DE)
Pipette Research
Pipetman
Proline Plus
Eppendorf (Hamburg, DE)
Gilson (Middelton, USA)
Satorius (Göttingen, DE)
Pipette Controller Accu-Jet pro Brand (Wertheim, DE)
Power supply EPS 301/601 Amersham plc, GE
Healthcare, Freiburg, DE)
Sonicator Bioruptor® Pico Diagenode (Denville,
USA)
Spectrophotometer Nano Drop ND1.000 Peqlab (Erlangen, DE)
Stereo microscope M205FA Leica microsystems
(Wetzlar, DE)
Thermocycler DNAEngine
S1000 Thermal Cycler
Bio-Rad (München, DE)
Bio-Rad (München, DE)
Thermomixer Thermomixer comfort
Thermomixer compact
Eppendorf (Hamburg, DE)
Eppendorf (Hamburg, DE)
Ultrapure water device Arium 611 Sartorius (Göttingen, DE)
Vertical tube rotator model LD-79 Labinco B.V. (Breda,
Netherlands)
Vortex Vortex-Genie 1 Scientific Industries (New
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Equipment Name Supplier
York, USA)
Water bath Water bath GFL Laborbedarf
(Braunschweig, DE)
2.1.2 Consumables
All consumables used in this study is listed in table 2.2.
Table 2.2: Consumables
Applic
ation
Consumables Supplier
Gener
al
Multiply-μStrip Pro 8-strip Sarstedt (Nürmbrecht, DE)
Parafilm American National Can (Chicago,
USA)
Pasteur pipettes (3 mL) Hartenstein (Würzburg, DE)
Petri dish 10 cm Greiner Bio-One (Frickenhausen,
DE)
Pipette tips 10 μL; 200 μL; 1000
μL; 5000 μL
Sarstedt (Nürmbrecht, DE)
Biohit/Satorius (Göttingen, DE)
Pipette filter tips 10 μL; 200 μL;
1000 μL
Sarstedt (Nürmbrecht, DE),
NerbePlus (Winsen, DE)
Polypropylene centrifugation
tubes (15 mL, 50 mL)
Corning (New York, USA)
Polystyrene lid Greiner Bio-One (Frickenhausen,
DE)
Reaction tube 1.5 mL; 2 mL Sarstedt (Nürmbrecht, DE)
Sterile syringe needle 26g TERUMO (Eschborn, DE)
Syringe Inject 1 mL, 2 mL 5 mL, B. Braun (Melsungen, DE)
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Applic
ation
Consumables Supplier
20 mL
Bacteri
al
culture
Air-o-Seal hydrophobic Gas
permeable seal
4titude (Dorking, UK)
Disposable Cuvettes 1.5 mL
half-micro
Brand (Wertheim, DE)
Disposable spatula (L-shape) VWR (Darmstadt, DE)
Inoculation loops Sarstedt (Nürmbrecht, DE)
Microtiter-polypropylene plate 96
well, U-shape
Greiner Bio-One (Frickenhausen,
DE)
Screw Cap Micro Tube (2 mL) Sarstedt (Nürmbrecht, DE)
Cell
culture
BD Falcon Cell Strainer (40 μm) FALCON/BD Bioscience
(Heidelberg, DE)
Cryo tube vials (2 mL) Nunc/ Thermo Scientific
EasyStrainer (40 μm) Greiner Bio-One (Solingen, DE)
Electroporation Cuvettes (0.4 cm) Kisker (Steinfurt, DE)
Glass coverslips Heinz Herenz Medizinalbedarf
GmbH (Hamburg, DE)
Neubauer chamber Henneberg-Sander GmbH
(Giessen, DE)
Petri dishes 10 cm Sarstedt (Nürmbrecht, DE)
Polycarbonate Erlenmeyer Flask
graduated
Corning (New York, USA)
Polystyrene TC plate 12/24/96x
wells
SPL Life Sciences (Pocheon,
KOR)
Serological pipettes (2, 5, 10, 25
mL)
Corning (New York, USA)
TC plate 96 well V shape with lid Greiner Bio-One (Frickenhausen,
DE)
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Applic
ation
Consumables Supplier
Ultra-Low attachment 6-well
plates
CELLSTAR/Greiner Bio-one
(Frickenhausen, DE)
ELISA Polystyrene assay plate 96x Well
(high binding)
Corning (New York, USA)
Flow
Cytom
etry
Deepwell plates, Protein LoBind,
96 wells
Eppendorf (Hamburg, DE)
Filter CellTrics 50 μm Sysmex (Norderstedt, DE)
Polystyrene lid Greiner Bio-One (Frickenhausen,
DE)
Protein
A
purifica
tion
system
Uniplate PP (10 mL)
Unifilter (10 mL)
Melt blown PP (10 μm)
MabSelect SuRe Protein A affinity
matrix
Whatman/GE Healthcare
(Freiburg, DE)
Zeba™ Spin Desalting Columns
89892
Thermo Scientific, DE
Wester
n blot
Blotting paper (550 g/m2) Sartorius (Göttingen, DE)
PVDF membrane Bio-Rad (München, DE)
Whatman filter paper Whatman/GE Healthcare
(Freiburg, DE)
2.1.3 Chemicals
All chemicals used were purchased from Carl Roth, Sigma-Aldrich,
Merck, AppliChem, Roche, and SERVA GmbH (all located in DE).
2.1.4 Buffers and solutions
All buffers and solutions used in this study are listed in tables 2.3 and 2.4.
Materials and Methods
26
Buffer and solutions were prepared with ultrapure water or as indicated
in the table.
Table 2.3: Buffers and solutions prepared in house
Application Buffer/ Solution Recipe
General Glycerine 80 % (v/v) Glycerine
PBS 137 mM NaCl; 1.76 mM KH2PO4 • 2 H2O
PBS-T 0.05 % (v/v) Tween20 in PBS
DNA
electrophore
sis
Agarose gel 1 % (w/v) Agarose in TAE
Ethidium
bromide solution
0.01 % (w/v) Ethidium bromide
TAE buffer 40 mM Tris; 20 mM Acetate; 2 mM EDTA
Coomassie
staining
Coomassie®-
Destaining
10 % (v/v) Acetic acid
Coomassie®-
Staining
10 % (v/v) Acetic acid, 0.05 % (w/v)
Coomassie® Brilliant Blue R250
ELISA ELISA stop
solution
1 N H2SO4
PBST
ELISA-Washer
0.05 % (v/v) Tween20 in PBS
M-PBST
(Blocking)
2 % (w/v) Milk powder in PBS; 0.05 %
Tween20
TMB solution A 30 mM Potassium citrate; 1 % (w/v) Citric
acid (pH 4.1)
TMB solution B 10 mM Tetramethylbenzidine; 10 % (v/v)
Acetone; 90 % (v/v) Ethanol; 80 mM H2O2
(30 %)
TMB solution 20 parts TMB-A; 1 part TMB-B
SDS-PAGE APS-solution 10 % (w/v) Ammonium persulfate in H2O
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Application Buffer/ Solution Recipe
Laemmli buffer
(5x)
500 g/L Glycerine; 100 g/L SDS; 250 mL
β-Mercaptoethanol; 200 mL 1.5 M Tris-HCl
(pH 6.8); 0.5 g/L Bromphenol Blue
SDS solution 10 % (w/v) SDS
SDS-PAGE
buffer
25 mM Tris; 192 mM Glycine; 0.1 % (w/v)
SDS solution
Acrylamide mix 30 % (w/v) Acrylamide, 0.8 % (w/v)
Bisacrylamide
Western
blot and
Immunostai
ning
AP substrate
buffer
100 mM Tris; 0.5 mM MgCl2 (pH 9.5)
BCIP solution 1.5 % (w/v) BCIP in 100 % (v/v)
Dimethylformamide
Blotting buffer 25 mM Tris; 192 mM Glycine (pH 8.3)
MPBS (Blocking) 2 % (w/v) Milk powder in PBS-T
NBT solution 3 % (w/v) NBT in 70 % (v/v)
Dimethylformamide
Flow
Cytometry
FACS buffer 0.5 % BSA, 5 mM EDTA in 1x PBS
Whole
mount
immunostai
ning
Fixation and
permeabilization
4 % PFA, 0.1 % Triton X-100 in PBS
Washing 0.1 % Triton X-100 in PBS
Antigen retrieval Ultrapure acetone (Panreac AppliChem,
Darmstadt, DE)
Blocking 5 % goat normal serum, 1 % BSA, 1 % Triton
X-100, DMSO in PBS
Staining solution 1 % BSA, 1 % Triton X-100 and 1 % DMSO
Protein A
purification
Washing1 PBS
Washing2 100 mM sodium citrate buffer pH 5.0
Elution 100 mM sodium citrate buffer pH 3.0
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Application Buffer/ Solution Recipe
Neutralization
solution
1 M tris-HCl pH 9.0
Zebrafish
embryo
solution
Danieau 30 % 5.8 mM sodium chloride, 0.07 mM potassium
chloride, 0.04 mM magnesium sulfate, 0.06
mM calcium nitrate, 5 mM HEPES
(2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesul
fonic acid), pH 7.2
Table 2.4: Commercial solutions and buffers
Application Buffer/ Solution Supplier
DNA cloning 5x Phusion® HF Buffer New England Biolabs (Frankfurt a.
M., DE)
6x loading dye Fermentas, (St. Leon-Rot, DE)
CutSmart buffer/NEBuffer
endonuclease specific
New England Biolabs (Frankfurt a.
M., DE)
GeneRulerTM 1kb Plus
DNA Ladder
Fermentas, St. Leon-Rot, DE
GoTag®Flexi Buffer Promega (Mannheim, DE)
Magnesium Chloride
Solution
Promega (Mannheim, DE)
T4 DNA Ligase Reaction
Buffer
New England Biolabs (Frankfurt a.
M., DE)
Protein
markers
Precision Plus ProteinTM
Standards unstained
Bio-Rad (München, DE)
Precision Plus ProteinTM All
Blue
Prestained Protein
Standards
Bio-Rad (München, DE)
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Application Buffer/ Solution Supplier
DNA/RNA
microinjecti
on
Red phenol Sigma (Steinheim, DE)
HPLC-grade water
(RNase-Free)
Carl Roth GmbH (Karsruhe, DE)
Zebrafish
embryo
treatment
Propylthiouracil (PTU) Sigma (Steinheim, DE)
Tricaine Sigma (Steinheim, DE)
Immunostai
ning
SuperSignal West Pico
Plus
Chemiluminescent
Substrate
Thermo Scientific, DE
Paraformaldehyde Merck (Darmstadt, DE)
Triton X-100 Bio-Rad (Münich, DE)
Acetone ultrapure Panreac AppliChem (Darmstadt,
DE)
goat normal serum Vector labs/BIOZOL (Eching, DE)
Dimethyl sulfoxide
(DMSO)
Carl Roth GmbH (Karsruhe, DE)
2.1.5 Media, supplements, and solutions
Media, supplements, and solutions for the cultivation of Prokaryotic or
Eukaryotic cells used in this study are listed respectively in tables 2.5
and 2.6. Media for bacterial culture without supplements were
autoclaved for 20 min at 121 °C and 1 bar.
Table 2.5: Media and supplements for E.coli culture
Medium/
supplement
Recipe
Media SOC 2 % (w/v) Tryptone; 0.5 % (w/v) Yeast extract;
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Medium/
supplement
Recipe
0.05 % (w/v) NaCl (pH 7.0); 20 mM Mg2+ solution
(1 M MgCl2, 1 M MgSO4); 20 mM Glucose
LB 1 % (w/v) Tryptone; 0.5 % (w/v) Yeast extract; 1 %
(w/v) NaCl
2xYT 1.6 % (w/v) Tryptone; 1 % (w/v) Yeast extract; 0.5 %
(w/v) NaCl (pH 7.0)
2xYT-GA 2xYT medium; 100 mM D-Glucose; 100 μg/mL
Ampicillin
2xYT-GA-Agar 2xYT medium; 1.5 % (w/v) Agar; 100 mM
D-Glucose; 100 μg/mL Ampicillin
Supple
ments
Ampicillin
solution
100 mg/mL Stock solution
Glucose
solution
2 M Glucose Stock solution
IPTG solution 1 M Isopropyl-β-D-thiogalactopyranosid Stock
solution
Tetracycline
solution
10 mg/mL Stock solution
Table 2.6: Media and supplements for Eukaryotic cell culture
Product Supplier Catalog
number
Media DMEM gibco® (Life Technologies,
Darmstadt, DE)
11965092
Free StyleTM F17
Expression medium
A13835-01
Leibovitz's L-15 medium 11415049
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Product Supplier Catalog
number
Solution
s
Collagenase (Type 2) Thermo Scientific (Waltham,
USA)
17101015
Bambanker freezing
medium
NIPPON Genetics (Düren,
DE)
BB01
Opti-MEM™ gibco® (Life Technologies,
Darmstadt, DE)
31985062
PBS (Dulbecco's
Phosphate
Buffered Saline)
14190-169
Polyethylenimine (PEI)
MAX, 40 KDa
Polysciences, Warrington,
USA).
24765-1
Poly-L-lysine Biochrom (Berlin, DE) L 7240
Trypsin/EDTA Biochrom (Berlin, DE) L2153
Supple
ments
Penicillin/streptomycin Biochrom (Berlin, DE) A2212
L-Glutamine Biochrom (Berlin, DE) K0283
Fetal bovine serum
(FBS)
Biochrom (Berlin, DE) S0615
DMSO Carl Roth (Karsruhe, DE) A994.2
Pluronic-F68 PANTM BIOTECH
(Aidenbach, DE)
P08-02100
TNFα gibco® (Life Technologies,
Darmstadt, DE)
PHC3015
Tryptone N1 (casein
peptone)
Organotechnie (La
Courneuve, France)
19553
2.1.6 Bacterial strains and bacteriophages
The bacterial strains used in this study are listed in table 2.7.
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Table 2.7: Bacterial strains and bacteriophages
Cell line Note References
E. coli XL1-Blue
MRF`
_(mcrA)183
_(mcrCB-hsdSMR-mrr)173 endA1
supE44 thi-1 recA1 gyrA96 relA1 lac
[F_ proAB lacIqZ_M15 Tn10 (Tetr)]
Stratagene (LA
Jolla, USA)
E. coli TG1 K-12 supE thi-1 _(lac-proAB)
_(mcrB-hsdSM)5, (rK-mK-) F'
[traD36 proAB+ lacIq lacZ_M15]
GE Healthcare
(Freiburg, DE)
Hyperphage
M13K07∆gIII
- Rondot et al.,
2001
M13K07 - Vieira and
Messing, 1987
2.1.7 Eukaryotic cell lines
The cell lines used in this study are listed in table 2.8.
Table 2.8: Eukaryotic cell lines
Cell line Note References
HEK293 (human) Adherent, epithelial, tumorigenic ATCC (CRL-1573)
Expi293F™ Cells
(human)
Derived from HEK293-6E cells,
optimized for growth in higher
densities in suspension.
Thermo Fisher
Scientific Inc.
(Waltham, USA)
PAC2 cells
(zebrafish)
Spontaneously immortalized.
Fibroblast.
CVCL_5853
2.1.8 Zebrafish lines
Zebrafish lines used in this study are listed in table 2.9.
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Table 2.9: Zebrafish lines
Fish line Genotype References
AB Wild-type Streisinger, 1981;
(ZIRC)
Brass Brs+ Postlethwait et al.,
1994
parachute (pac)
cdh2 mutant
cdh2 r2.10 heterozygote Lele et al., 2002
zf516 Tg
(Cdh2-sfGFP-Ta
gRFP)
TgBAC(cdh2:cdh2-sfGFP-TagRFP,
crybb1:ECFP) inserted on a cdh2
parachute genetic background (pac,
allele tm101b)
Revenu et al., 2014;
Jiang et al., 1996
Tg(atoh1a:KalTA
4)
atoh1a:KalTA4 construct genome
integrated on wild-type background
Distel et al., 2010
Tg(4xUAS:GFP) 4xUAS:GFP construct genome
integrated on wild-type background
Distel et al., 2010
2.1.9 Expression vectors
Expression vectors used in this study are listed in table 2.10.
Table 2.10: Expression vectors
Plasmid Description Reference
pCSE2.6-(scFv)hIgG1-F
c
scFv-hFc antibody production
in HEK293-6E cells
Beer et al., 2018
pCSE2.6-(antigen)mIgG
2a-Fc-Xp
Cadherin 2 ECD and
ECD-domains production as
mouse Fc-fusion in
Miethe et al., 2015
Materials and Methods
34
Plasmid Description Reference
HEK293-6E cells
pHAL30 (Phagemid) Antibody Phage-Display and
soluble scFv production in E.
coli
Kügler et al.,
2015
Tol1 donor vector Transposon-donor plasmid
containing the cassette for
genome integration
Provided by
A. Koga Lab
Tol2 donor vector Transposon-donor plasmid
containing the cassette for
genome integration
Provided by
K. Kawakami Lab
pKJ-Tol2
transposase(A25)
(internal database
#3816))
Vector for Tol2 transposase
mRNA in vitro synthesis
Provided by
K. Namikawa
pCMV-mp75NTR-YFP Mouse p75-YFP eukaryotic
expression vector
Zhang et al., 2012
pCMV-scFv
α-phOx-KDEL
Eukaryotic expression of ER
intrabody to PhOx
Zhang et al., 2012
pCMV-scFv α-p75-KDEL Eukaryotic expression of
SH325-G7 ER intrabody to
mouse p75
Zhang et al., 2012
2.1.10 Enzymes
All enzymes and related buffers used in this study are listed in table
2.11.
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Table 2.11: Enzymes
Product Supplier Catalog
number
Calf Intestinal alkaline
Phosphatase
New England Biolabs (Frankfurt
a. M., DE)
M0290
Collagenase (Type 2) Thermo Scientific, DE 17101015
GoTaq®
DNA-Polymerase
Promega (Mannheim, DE) M300
Phusion
DNA-Polymerase
New England Biolabs (Frankfurt
a. M., DE)
M0530
Restriction
endonucleases
-
T4 DNA Ligase Promega (Mannheim, DE) M180A
Trypsin Sigma-Aldrich (Taufkirchen, DE) -
Trypsin/EDTA Biochrom L2153
2.1.11 Commercial antibodies
Commercial antibodies used in this study are listed in table 2.12.
Table 2.12: Commercial antibodies
Antibody Conjug
ation
Catalog No/
Clone name
Supplier/ Origin
Rabbit α- zebrafish
Cdh2
- GTX125885 GeneTex (BIOZOL,
Eching, DE)
Mouse α-p75 NGF
Receptor (muse, rat)
(monoclonal)
- ab61425 Abcam (Berlin, DE)
Mouse α-c-Myc - 9E10 Produced in house
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(monoclonal)
goat α-mouse IgG (Fc) HRP A0168 Sigma-Aldrich (Hamburg,
DE)
goat α-hIgG (Fc) AP 109-055-098 Dianova (Hamburg, DE)
goat α-hIgG (Fc) HRP A0170 Sigma-Aldrich (Hamburg,
DE)
goat α-human IgG (Fc) FITC 109-095-098 Dianova (Hamburg, DE)
goat α-human IgG (Fc) FITC F9512 Sigma-Aldrich (Hamburg,
DE)
goat α-human IgG (Fc) APC 109-135-098 Dianova (Hamburg, DE)
rat anti-human IgG
(Fc) (monoclonal)
APC M1310G05 Biolegend/BIOZOL
(Eching, DE)
goat anti-rabbit IgG (H
+ L)
Cy3 111-136-144 Dianova (Hamburg, DE)
goat α-mouse IgG (Fc) FITC F5897 Sigma-Aldrich (Hamburg,
DE)
goat α-mouse IgG (Fc) APC 115-136-072 Jackson ImmunoResearch
(Ely, UK)
2.1.12 Commercial kits
Commercial kits used in this study are listed in table 2.13.
Table 2.13: Commercial kits
Kit Description Supplier
NucleoBond®PC500 Xtra
Midi
Preparation of
plasmid DNA
Macherey-Nagel (Düren, DE)
NucleoSpin® Plasmid
easy pure
Preparation of
plasmid DNA
Macherey-Nagel (Düren, DE)
NucleoSpin® Gel and
PCR clean-up
Clean up of
DNA-fragments
Macherey-Nagel (Düren, DE)
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2.1.13 Bioinformatics software
Bioinformatics software used in this study are listed in table 2.14.
Table 2.14: Bioinformatics software
Software Reference Purpose
Image Lab
Software
Bio-Rad ChemiDoc MP images
processing
VBase2 Mollova et al., 2010 Analysis of antibody
sequences
ImageJ Schneider et al., 2012
Leica Las X Leica microsystems
PyMol v1.3 The PyMOL Molecular Graphics
System, Schrödinger, LLC.
Molecular visualization
SH-800
software
https://www.sonybiotechnology.
com/us/instruments/sh800s-cell
-sorter/software/
Flow cytometry analysis
and
data visualization
CytExpert 1.2
software
https://www.beckman.com/coult
er-flow-cytometers/cytoflex/cyte
xpert
Weasel http://www.frankbattye.com.au/
Weasel/?utm_source=Chromoc
yte&utm_medium=Educate
Mendeley https://www.mendeley.com Reference management
SWISS-MODE
L
Arnold et al., 2006 Protein structure homology
modelling
NCBI http://www.ncbi.uhm.nih.gov Literature, Protein- and
Gene-sequences
LibreOffice
Suite
https://de.libreoffice.org Text and Data
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WPS Suite https://www.wps.com/ Text and Data
Inkscape 0.91 https://inkscape.org/ Figures editor
Geneious
4.8.5
https://www.geneious.com In silico cloning, sequence
analysis
GraphPad
Prism 6
Prism version 6.00 for Windows,
GraphPad Software, La Jolla
California USA,
www.graphpad.com
scFv-hFc antibody EC50
values calculation from
titration ELISA results
2.1.14 Oligonucleotide primers
Oligonucleotide primers used in this study are listed in table 2.15.
Table 2.15: Oligonucleotide primers list
Prime
r ID Primer name Seq 5' → 3'
2563 zCdh2-ECD1_BssHII_f ATATGCGCGCACTCCATGTGGGTCATTCCTCCTG
3035 zCdh2-ECD1_NotI_r ATGTGCGGCCGCGAACTCTGGCCGGTTGTC
3036 zCdh2-ECD2_BssHIII_f ATATGCGCGCACTCCACACACCAGATCTGGAATGG
2561 zCdh2-ECD2_NotI_r TAATGCGGCCGCGAACTCGGGAGCG
3037 zCdh2 148-207_NotI_r TAATGCGGCCGCAGAGAGAAGTCCTGAAATGG
3038 zCdh2195-273_BssHII_f
ATATGCGCGCACTCCGGCCTGTTTATCATC
GACC
3039 zCdh2 195-273_NotI_r TAATGCGGCCGCTACGAATGTTCCTGGTTTGG
3040 zCdh2 ATATGCGCGCACTCCGTGGATGAGGGTGC
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263-324_BssHII_f CAAAC
3041 zCdh2 263-324_NotI_r TAATGCGGCCGCCAGGCCTGCAGCTACTG
3042 zCdh2315-369_BssHII_f
ATATGCGCGCACTCCGGCAAAATCATCACA
GTAGC
2562 zCdh2propeptide_BssHII_f
ATATGCGCGCACTCCATGCCATGTCAGCCT
G
2560 zCdh2-ECD5_NotI_r TAATGCGGCCGCGATGCGCTCCATGTC
2815 zCdh2_PvuII_f AGCTCAGCTGAGTCTGAAGATTAG
2817 zCdh2_XbaI_r ATCATCTAGATTTATTTATCCCGTCTCTTCATCC
3757 hCdh2-BssHII_f ATTAGCGCGCACTCCTCTGGTGAAATCGCATTATGC
3758 hCdh2-NotI_r TAATGCGGCCGCAATCCTGTCCACATCTGTGC
3211 Linker-mClover_NotI_f ATTAGCGGCCGCGGATCCACCGGTCGCCACCGTGAGCAAGGGCGAGG
3212 mClover_XbaI_r ATCATCTAGATTTACTTGTACAGCTCGTCCATGC
2849 tagRFP-T_EcoRV_f ATTAGATATCGCAAACATGGTGTCTAAGGGCGAAG
2850 tagRFP-T_XbaI_r ATGGTCTAGATTACTTGTACAGCTCGTCCATGC
2701 mCMV CpG-free-PacI_f GCCGTTAATTAAGAGTCAATGGGAAAAACCCAT
2702 mCMV CpG-free-SbfI_r ATTACCTGCAGGCACCCCTATTGACCTTATGTATG
2703 xEF1a-PacI_f CGCGTTAATTAACAGGGGGATCATCTAATCAAG
2704 xEF1a-SbfI_r ATATCCTGCAGGGCATGCCTGAGAATTTCAG
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2831 xEF1a_NheI_for ATATGCTAGCAGGATCATCTAATCAAGCACAAATAAGG
2832 xEF1a_BamHI_rev TCATGGATCCAGAGAATTTCAGAATGTAATGATACCTTTG
2851 Intrab.cassette_EcoRI_f AGATGAATTCGCAAACATGCACAAGG
2852 Intrab.cassette_XhoI_r GCATCTCGAGTTTATAGTTCGTCCTTTAGATCTTCTTCTG
Materials and Methods
41
2.2 Methods
2.2.1 Molecular biology techniques
2.2.1.1 DNA amplification via PCR
2.2.1.1.1 DNA polymerases
In this study we used two different polymerases based on the purpose of
the experiment experiment. GoTaq DNA polymerase (Promega) was
used in Colony-PCR reactions to determine insert length after cloning.
Phusion® High-Fidelity DNA Polymerase (NEB, Thermo Scientific) was
used for the amplification of coding or non-coding DNA to be used as
insert in the generation of new plasmid.
2.2.1.1.2 Colony-PCR
Colony-PCR was used to confirm the presence of the correct insert after
cloning into the desired vector backbone. Indirectly, it constituted a
method to validate the success of the cloning experiments. The primer
pair used for each Colony-PCR was based on the destination vector
used. This allowed to generate an amplicon also in the absence of a
correctly ligated insert. Colony-PCR reaction mix was prepared as
shown in table 2.16, while the temperature profile of the reaction in table
2.17.
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Table 2.16: Colony-PCR reaction mix
Component Volume (µL) Final Concentration
Material from single bacterial colony /
5x GoTaq Flexi Buffer (green) 2 1 X
MgCl2 [25 mM] 0,8 2 mM
dNTPs mix [10 mM] 0,5 0.5 mM
Primer F [10 µM 0,5 0.5 µM
Primer R [10 µM] 0,5 0.5 µM
GoTaq-Polymerase [5 U/µL] 0,05 0,025 U/µL
dH2O 5.65
10 µL
Table 2.17: Colony-PCR reaction temperature profile
Step Temperature (°C) Time(min:s)
Cycle
s
Bacterial cell lysis and DNA
denaturation 95 2:00 1x
DNA denaturation 94 0:30
29xAnnealing
Depending on
primer pair & DNA
polymerase in use
0:30
Elongation 72 1 min/Kb
Final elongation 72 5:00 1x
Conservation 16 ∞
2.2.1.1.3 High-Fidelity polymerase DNA amplification
The DNAEngine, or the S1000 Thermal Cycler, Bio-Rad thermocyclers
were used for the amplification of the DNA fragment of interest.
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Primers were designed to add specific restriction site ends for direct
cloning into the destination vector. The different DNA templates and
primer pairs used for the generation of the antigen vectors are shown in
table 2.18. PCR reaction mix was prepared as shown in table 2.19, while
the temperature profile of the reaction in table 2.20.
Table 2.18: Oligonucleotide primers and vectors for antigen cloning
Final vector Primer pair Destination
vector
PCR
template
Cloning
pCSE2.6-zCdh2-ECD
1-2-hIgG1Fc
# 2561
# 2563
pCSE2.6-hIgG1
Fc-XP
Zebrafish
brain cDNA
BssHII - NotI
pCSE2.6-zCdh2-ECD
1-5-mIgG2aFc
# 2560
# 2562
pCSE2.6-mIgG
2aFc-XP
Zebrafish
brain cDNA
BssHII - NotI
pCSE2.6-zCdh2-ECD
1-2-mIgG2aFc
# 2561
# 2563
pCSE2.6-mIgG
2aFc-XP
Zebrafish
brain cDNA
BssHII - NotI
pCSE2.6-zCdh2-ECD
1-mIgG2aFc
# 3035
# 2563
pCSE2.6-mIgG
2aFc-XP
Zebrafish
brain cDNA
BssHII - NotI
pCSE2.6-zCdh2-ECD
2-mIgG2aFc
# 2561
# 3036
pCSE2.6-mIgG
2aFc-XP
Zebrafish
brain cDNA
BssHII - NotI
pCSE2.6-zCdh2-ECD
-148-207-mIgG2aFc
# 2563
# 3037
pCSE2.6-mIgG
2aFc-XP
Zebrafish
brain cDNA
BssHII - NotI
pCSE2.6-zCdh2-ECD
-195-273-mIgG2aFc
# 3038
# 3039
pCSE2.6-mIgG
2aFc-XP
Zebrafish
brain cDNA
BssHII - NotI
pCSE2.6-zCdh2-ECD
-263-324-mIgG2aFc
# 3040
# 3041
pCSE2.6-mIgG
2aFc-XP
Zebrafish
brain cDNA
BssHII - NotI
pCSE2.6-zCdh2-ECD
-315-369-mIgG2aFc
# 2561
# 3042
pCSE2.6-mIgG
2aFc-XP
Zebrafish
brain cDNA
BssHII - NotI
pCSE2.6-hCdh2-ECD
1-5-mIgG2aFc
# 3757
# 3759
pCSE2.6-mIgG
2aFc-XP
HEK293
cDNA
BssHII - NotI
pCSE2.6-zCdh2-ECD # 3211 pCSE2.6-zCdh pCS2-mClov NotI - XbaI
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-TM-mClover # 3212 2-LSSmKate2
(GiR094-1)
er
pCSE2.6-zCdh2-trunc
ated (aa 147-738)
# 2815
# 2817
pCSE2.6-zCdh
2-ECD1-5-hIgG
1Fc (GiR054-1)
zCdh2 whole
length gene
PvuII - XbaI
Table 2.19: High-Fidelity polymerase reaction mix
Component Volume (µL) Final Concentration
Template DNA (pDNA/cDNA) 1 - 3 0.02 - 0.2 ng/µL
5x Phusion HF Buffer 10 1 X
dNTPs mix [10 mM] 1 0.2 mM
Primer F [10 µM] 2,5 0.5 µM
Primer R [10 µM] 2,5 0.5 µM
Phusion DNA Polymerase [2
U/µL] 0,75 0,03 U/µL
dH2O 30.25 - 32.25
50 µL
Table 2.20: High-Fidelity polymerase PCR temperature profile
Step Temperature (°C) Time(min:s) Cycles
Initial DNA
denaturation 98 2:00 1x
DNA denaturation 98 0:10
28x
(9x + 19x in
twp-steps PCR)
Annealing
Depending on
primer pair & DNA
polymerase in use
0:30
Elongation 72 1 min/Kb
Final elongation 72 5:00 1x
Conservation 16 ∞
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2.2.1.2 Agarose gel electrophoresis
Gels of 1 % (w/v) agarose in TAE buffer were used for analytic
separation of DNA. DNA fragment of different length were separated
electrophoretically applying a current of 120-130 V and 400 A for 20-35
min. For the UV visualization of DNA after the run, ethidium bromide was
added to the gel prior agar polymerization to a final concentration of 100
ng/mL. DNA samples were mixed with 6x loading dye (MBI Fermentas,
DE) before gel loading. GeneRuler 1 Kb DNA Ladder Mix (MBI
Fermentas, DE) was used as a marker. DNA detection under UV light (λ
 = 312 nm) was done using the ChemiDoc™ MP Imaging System
(Bio-Rad, München, DE).
2.2.1.3 Linear DNA purification
PCR products or DNA after endonuclease digestion were purified
directly or after gel extraction via NucleoSpin Gel and PCR Clean-Up
(Macherey-Nagel).
2.2.1.4 DNA quantification
Assessment of dsDNA concentration and purity after any DNA
preparation was assessed by measuring the absorbance at 260 nm and
280 nm with the use of a spectrophotometer (NanoDrop 1000, Peqlab,
DE). A ratio of A260nm/A280nm comprised between 1.84 and 1.94 was
considered as sufficiently pure for cell transfection or injection into
zebrafish embryo.
2.2.1.5 Restriction endonucleases digestion of DNA
Restriction enzyme digestion of PCR products, as well as destination
vectors, or insert present in pDNA were performed in a volume of 50 µL
for 1-2 h using NEB enzymes accordingly to the manufacturer protocol.
When available, the high fidelity (HF) version of the endonuclease was
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used. Restriction enzymes were always heat inactivated for 20 min at
the temperature indicated by the manufacturer, at 65 °C where heat
inactivation was not recommended.
2.2.1.6 Linearized vector backbone Dephosphorylation
Linearized vector DNA was dephosphorylated adding directly into the
endonuclease reaction 10U of calf intestinal alkaline phosphatase (CIP)
(NEB, USA) for 1 h.
2.2.1.7 DNA ligation
Insert and vector, in the molar ratio of 3.5:1, were ligated overnight at
16 °C or 1 h at RT with 1U T4 DNA Ligase (Promega, DE). For the
ligation reaction, 50 ng of destination vector DNA were used in a final
volume of 10 µL together with the insert. An additional ligation reaction
containing the destination vector alone was included in any experiment
as control.
2.2.1.8 Cloning validation and DNA sequencing
Identification of clones containing the newly generated expression
vector was made via Colony-PCR first and afterwards confirmed via
sequencing. In the cases the Colony-PCR could not be used to
discriminate between newly generated plasmid and negative control
plasmid, specific restriction digestions or direct sequencing were used to
verify cloning exactness. All DNA sequences were obtained from Seqlab
Sequence Laboratories Gmbh (Göttingen, DE).
2.2.1.9 Preparation of plasmid DNA
E. coli cells were isolated from the culture media via centrifugation and
used for plasmid DNA extraction using the NucleoSpin Plasmid kits
(Macherey & Nagel, DE) according to the manufacturer protocol.
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Plasmid DNA was always eluted with sterile ultrapure water.
2.2.1.10 Generation of scFv-hFc antibody construct
Selected genes of scFv antibodies to zCdh2-ECD1-2 were cloned into
the pCSE2.6-hIgG1-Fc-XP (Beer et al., 2018) mammalian expression
vector for production of bivalent scFv-hFc antibodies. NcoI - NotI cloning
allowed direct fusion in frame to the N-terminal signal peptide gene and
the C-terminal human Fc gene.
2.2.1.11 Generation of new enhancer/promoter expression
cassettes
Different enhancer/promoter combinations had to be tested for the
generation of a new CpG-free and bidirectional vectors suitable to drive
widespread gene expression in zebrafish in vivo as well as in eukaryotic
cell lines. In every construct the promoter element, Super Core Promoter
2 (SCP2), was kept constant, while the enhancer elements were
exchanged. To allow later characterization of each enhancer/promoter
combination, a fluorescent reporter gene was cloned per each side of
the bidirectional expression cassette. The expression cassette was
subcloned into the Tol2 donor vector (transposon-donor plasmid) to
allow its transposon mediated genome integration in zebrafish, resulting
in the following architecture:
Tol2 IR - pA - tagRFP-T ← SCP2 - Enhancer/s - spacer - Enhancer/s -
SCP2 → mClover - pA - Tol2 IR. The following enhancers were cloned
and tested alone or in combination: hCMV, mCMV, xEF1a, SV40. Finally,
SV40 and hCMV were discarded as resulting constructs did not meet
selection criteria. Two enhancer/promoter combinations were kept,
GiR077 (Figure 22) and GiR085-1 (Figure 17). The SCP2 CpG-free
sequence (Juven-Gershon et al., 2006), as well as the SV40 and
Xenopuse EF1a enhancer sequences, were generated via gene
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synthesis. Mouse and human CMV CpG-free enhancer sequences are
derived from pCpG-free-LacZ plasmids (Invivogen, Toulouse, France).
Fluorescent reporter protein genes were obtained from in-house
expression vectors. Oligonucleotide primers designed for DNA
amplification of the described genetic elements are shown in Table 2.15.
2.2.1.12 Generation of ER intrabody knockdown vectors
The ER intrabody expression cassette was generated via gene
synthesis and is constituted by the following elements in order from 5’ to
3’: zebrafish Kozak sequence - C.elegans signal peptide - NcoI-NotI
restriction site (for in frame scFv gene cloning) - HA-tag - Myc-tag -
KDEL peptide coding sequence - STOP codon. The cassette was cloned
on the right arm of GiR085-1 Tol2 vector (Figure 17) instead of the
fluorescent reporter mClover. Oligonucleotide primers designed for DNA
amplification of the ER intrabody expression cassette are shown in Table
2.15.
2.2.2 Microbiological methods
2.2.2.1 Preparation of E. coli culture
E. coli cells transformed with pDNA after ligation or derived from phage
infection were plated onto 2x YT-A agar plates and incubated ON at
37 °C. Single colonies were used to inoculate liquid 2x YT-A culture
containing or not 100 mM glucose, based on the vector (pHAL30 vector
with glucose; any eukaryotic expression vectors without glucose).
Cultures were incubated at 37 °C, overnight, shaking at 250 rpm and
used for glycerol stock preparation and plasmid DNA extraction.
2.2.2.2 Glycerol stocks
Bacteria clones of interest were stored in the form of glycerol stock at
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-80 °C. For the 20 % (w/v) glycerol stock preparation, 1 mL freshly
cultured E. coli cells were mixed with 333 μL of 80 % (w/v) glycerol in
cryogenic tubes (screw cap) and stored at -80 °C.
2.2.2.3 E. coli transformation and plating
Per each reaction, 20 µL of chemically competent E. coli cells were
thawed on ice. Afterwards, a maximum amount of 100 ng DNA from the
ligation were added to the bacteria and gently mixed prior 20 min
incubation on ice. Mixed DNA and bacteria were then incubated 60 sec
at 42°, followed by 2 min on ice, before adding 1 mL SOC medium
pre-warmed at 37 °C. At this point cells were incubated 1 h at 37 °C and
650 rpm in a Thermomixer. After 1 h cells were pelleted for 30 sec at
16,100 xg and resuspended in 100 µL of their own supernatant before
plating on 2x YT-AG agar plates. Plates were incubated 16 h at 37 °C.
2.2.3 Selection of human recombinant antibodies
For the selection of human antibodies to the zebrafish Cdh2 extracellular
domain, the first two extracellular domains of the molecule fused to
human Fc were used as antigen (zCdh2-ECD1-2-hFc). The antibody
selection (panning) was performed in 96 well microtiter plates (High
Binding Costar/Corning, New York, USA) on immobilized antigen as
previously shown (Russo et al., 2018, Methods Mol Biol.). Antibodies
binding to the target were selected from 1 × 1011 phage particles of
Hyperphage (Rondot et al., 2001; Soltes et al., 2007) packaged human
naïve antibody gene libraries HAL9/10 (Kügler et al., 2015). Ninety-two
mAb producing clones were randomly picked after three rounds of
panning. The 92 different soluble scFv antibodies produced were tested
in ELISA for presence of binding against the zCdh2-ECD1-2-hFc and
absence of binding to an unrelated hFc-fused protein. Antibody selection
here described has been performed by Saskia Helmsing.
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2.2.4 Biochemical methods
2.2.4.1 Affinity purification of Fc-fused proteins
One week after transfection, HEK293-6E supernatant was collected
after centrifugation (500 xg, 10 min) and used for Protein A affinity
chromatography on 24-well binding plates. These are made by three
components assembled together: a 10 mL Uniplate PP, a 10 mL Unifilter,
10 μm melt blown PP, and a MabSelect SuRe Protein A affinity matrix
(GE 7701-5110; GE 7700-9917; GE 17-5438-01; Whatman, Munich, DE).
After loading the sample onto the matrix, the matrix was washed first
with phosphate-buffered saline (PBS), then with 100 mM sodium citrate
buffer pH 5.0. Elution was performed in 1.5-2 mL of 100 mM sodium
citrate buffer pH 3.0. Fractions were neutralized by adding 1 M tris-HCl
pH 9.0. Buffer was exchanged to PBS using the Zeba™ Spin Desalting
column according to the manufactured protocol. Purified antibodies
integrity and purity was assessed in coomassie staining after
SDS-PAGE. Antibody solution was stored at ‑20 °C in 50-100 µL aliquots
or used directly. In the second case, antibodies were stored at 4 °C for
few months.
2.2.4.2 Determination of protein concentration
Purified protein concentration was assessed by measuring the
absorbance at 280 nm with the use of a spectrophotometer (NanoDrop
1000, Peqlab, DE). Measured concentration was adjusted based on the
calculated molecular weight and molar extinction coefficient (Geneious
4.8.5 bioinformatics tool).
2.2.4.3 SDS-PAGE
Protein samples were separated according to their electrophoretic
mobility in Sodium dodecyl sulfate polyacrylamide gel electrophoresis
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(SDS-PAGE). For a better resolution of high molecular weight proteins
10 % polyacrylamide gels were used, otherwise 12 % was preferred. Gel
composition is shown in Table 2.21.
Samples were mixed with Laemmli’s sample buffer containing
ß-Mercaptoethanol and incubated at 96 °C. Purified protein samples
were boiled for for 10 min, while cell lysate for 30 min. Samples were
directly used after preparation. HEK293 cell lysate, of untransfected
cells or cells transfected with the vector expressing zCdh2-ECD-mFc,
was prepared for 30 min at 95 °C with Laemmli SDS sample buffer
containing β-Mercaptoethanol (ß-ME) (reducing conditions) and loaded
onto a 10 % SDS polyacrylamide gel. Sample concentration was
approximately 80,000 cells per lane. Cell lysate sample was centrifuged
5 min at maximum speed before gel loading.
Purified protein samples were prepared also in SDS sample buffer
containing β-Mercaptoethanol (ß-ME), but boiled for only 10 min at
95 °C and loaded onto the gel at a concentration of 0.5 µg per lane.
Precision Plus protein standard (Bio-Rad, DE) was loaded onto the gel
as marker. Electrophoretic run was performed at 300 V, 20 mA per one
gel.
Table 2.21: Polyacrylamide gel preparation mix
Component Stackinggel (4 %)
Running
gel (10 %)
Running
gel (12 %)
30 % Acrylamide mix 0.26 mL 1.3 mL 1.6 mL
1.5 M Tris-HCl (pH 8.8) / 1.0 mL 1.0 mL
1 M Tris-HCl (pH 6.8) 0.20 mL / /
10 % (w/v) SDS 15 μL 40 μL 40 μL
10 % (w/v) APS 15 μL 40 μL 40 μL
TEMED 2 μL 2 μL 2 μL
dH2O 1.0 mL 1.6 mL 1.3 mL
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2.2.4.4 Coomassie blue staining
Every protein sample after affinity chromatography purification was
analyzed for purity, integrity, and degradation using Sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie
blue (Carl Roth GmbH, Karsruhe, DE) staining. Proteins on SDS-gels
were stained with Coomassie staining solution and de-stained in
destaining solution until protein bands were clearly distinguishable from
the background.
2.2.5 Cell culture methods
Cell manipulation described in this section was performed in sterile
conditions under a laminar flow clean bench using sterile consumables
and reagents.
2.2.5.1 HEK293 adherent cells culture
Human embryonic kidney 293 (HEK293) adherent cell line was cultured
in DMEM medium supplemented with 8 % FCS, 4.5 g/L glucose, and
100 μg/mL penicillin/streptomycin. Cells were maintained in 10 cm petri
dish at 37 °C, 5 % CO2, 96 % humidity. Cells at 80 - 90 % confluency
were washed with PBS and then detached with 1 mL trypsin/EDTA
solution. Trypsin was inhibited with 4 mL medium containing
supplements. Cells were seeded at a confluent state of ~10 % into new
plates containing 10 mL of pre-warmed fresh medium. Cell passage was
repeated every 2-3 days depending on the rate of cell division.
2.2.5.2 HEK293 adherent cells transfection
Each ER intrabody knockdown vector encoding for a specific
scFv-KDEL to zCdh2 and tagRFP-T was cotransfected together with
pCSE2.6-zCdh2-ECD-TM-mClover or pCSE2.6-zCdh2-truncated (aa
147-738) antigen vector in a 10:1 ratio. This particular DNA ratio was the
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result of optimization tests and depends on the different strength of the
enhancer/promoter used. The simian CMV IE94 enhancer/promoter of
the pCS2+ vector drives a much stronger expression than the
mCMV-xEF1a CpG-free enhancers combined to the SCP2 (ER
intrabody bidirectional vector). Per each transfection reaction 150 µL
Opti-MEM transfection medium were added into one well (DNA well) of a
48x well plate, while 125 µL Opti-MEM transfection medium were added
into a different well of the same plate (PEI well).
A total of 1820 ng of ER intrabody vector + 180 ng antigen vector were
added into the DNA well, while 8µL of PEI 25KDa were added into the
PEI well. The two wells were fused after some minutes and the DNA-PEI
solution thoroughly resuspended ten times. After 25 min incubation,
DNA-PEI complexes were added onto 70 % confluent cells in a 6x well
plate in 2 mL medium.
2.2.5.3 Fc-fusion protein production in HEK293-6E
Suspension HEK293-EBNA1-6E (HEK293-6E) cells were cultured in
F17 medium (Invitrogen, Life Technologies) supplemented with 7.5 mM
L-glutamine, 0.1 % Pluronic-F68. Cells for transfection were maintained
by Doris Meier.
For transfection, mammalian expression vector (5 µg) and PEI (25 µg)
were thoroughly mixed in 500 µL transfection medium and incubated at
RT. After 20 min incubation, the DNA-PEI mix was added to 5 mL
HEK293-6E culture at the density of 1.5x106 cells/mL and incubated at
37 °C, 5 % CO2, and 190 rpm (50 mm orbital). After 48 h, 5 mL of cell
culture medium containing 0.5 % Tryptone N1 were added to the culture
and the incubation prolonged for other 120 h. The presence in the
mammalian expression vector used for transfection of a N-terminal
signal peptide, in frame with the gene of interest, allows for antigen or
antibody secretion into the cell supernatant.
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2.2.5.4 Zebrafish PAC2 cell culture conditions
Zebrafish fibroblast cells are non-directly-immortalized cells obtained
from embryonic zebrafish. Hence, the growth rate of these cells is
particularly low compared to standard immortalized cell lines. Also, these
cells are particularly sensitive to low levels of confluency and were
always kept at a confluency higher than 30 %. PAC2 cells were cultured
in Leibovitz's L-15 medium supplemented with 10 % FCS and 100 μg/mL
penicillin/streptomycin. Cells were maintained in 10 cm petri dish at
28 °C without CO2. Cells at ~90 % confluency were washed with PBS
and then detached with 1.5 mL trypsin/EDTA solution. Incubation time
required for the dissociation may vary, but it was never inferior to 10 min.
Trypsin was inhibited with 4 mL medium containing supplements. Cells
were seeded at a confluent state of ~30 % into new plates containing 10
mL of pre-warmed fresh medium. Cell passage was repeated every 5-7
days depending on the rate of cell division.
2.2.5.5 Transfection of zebrafish cells via electroporation
For electroporation, zebrafish cells were pelleted by centrifugation,
resuspended in sterile 1x PBS, and diluted to a final concentration of 106
cells in 350 µL. Afterwards, 350 µL cell solution was mixed with 20 µg
DNA and the solution adjusted to 400 µL adding sterile ultrapure water.
Mix has been gently resuspended bu pipetting up-and-down for at least
20 sec, before being transferred into a 0.4 cm gap electroporation
cuvette. Samples were electroporated using the Gene Pulser XcellTM
Electroporation System (BIO-RAD) using the parameters shown in Table
2.22. If necessary, because of limiting DNA or cells availability, the
electroporation reaction mix has been scaled down to a maximum of
0.5x106 cells plus 10 µg DNA in a volume of 100 µL. For electroporation
of multiple constructs, same overall amount of DNA was used, but
equally split by the number of the constructs used.
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Table 2.22: DNA Electroporation - Exponential decay protocol
PAC2 cells Primary cells
Voltage (V) 250 V 280 V
Capacitance (µF) 950 µF 950 µF
Resistance (ohm) PBS R < 30 ohm PBS R < 30 ohm
Cuvette 4 mm 4 mm
Buffer PBS PBS
2.2.5.6 Zebrafish PAC2 cells preparation for FACS analysis
PAC2 cells after electroporation were directly seeded into Ultra-Low
attachment 6-well plates (CELLSTAR 657185, Greiner Bio-one,
Frickenhausen, DE) at a concentration of 1×106 cells/well in 2 mL
Leibovitz's L-15 Medium supplemented with 10 % FCS and 1 %
Pen./Strep. Cells were incubated at 28 °C w/o CO2 before
immunostaining and flow cytometry analysis. The use of Ultra-Low
attachment plates allowed to mechanically detach the cells without any
need of enzymatic dissociation. Most of the proteases used for cell
detachment or tissue dissociation (including trypsin and collagenase)
impair the display of Cdh2.
2.2.5.7 Zebrafish embryonic primary cell preparation for FACS
analysis
Single cell suspension from 3 dpf zebrafish Wt, parachute, and zf516 Tg
larvae (obtained as described in paragraph 2.2.6.5) was seeded into
Ultra-Low attachment 6-well plates (CELLSTAR 657185, Greiner
Bio-one, Frickenhausen, DE) in Leibovitz's L-15 Medium supplemented
with 10 % FCS and 1 % Pen./Strep. at a concentration of 1-2 × 106/mL.
Cells were incubated at 28 °C w/o CO2 until immunostaining and flow
cytometry analysis. The use of Ultra-Low attachment plates allowed to
detach the cells without any need of enzymatic dissociation.
Materials and Methods
56
2.2.5.8 Zebrafish embryonic primary cell culture for confocal
imaging
Primary embryonic zebrafish cells were obtained and cultured as
previously described (Sassen et al., 2017; Russo et al., 2018, JoVE).
Single cell suspension after electroporation was seeded directly on
poly-L-lysine-coated glass bottom dish for confocal microscopy. A total of
0.5x106 electroporated cells per dish were seeded in 500 µL. After 1 h
incubation, 6 mL of complete medium was added and the cells
incubated at 28 °C without CO2. Half of the medium volume was daily
replaced with fresh medium. At 48 h in culture cells were imaged at the
confocal laser scanning microscope SP8 (Leica microsystems, Wetzlar,
DE).
2.2.5.9 Zebrafish embryonic primary cell culture for TNFα treatment
Embryonic primary zebrafish cells (obtained as described in paragraph
2.2.6.5) were seeded at a density of 0.1x106 cells/well onto
poly-L-lysine-coated 96-well plate and incubated ON in L-15 medium
supplemented with 10 % FCS and 100 μg/mL penicillin/streptomycin.
The morning after, medium was completely replaced with starvation
medium containing only 1 % FCS. Eight hours post starvation, TNFα
was added to a final concentration of 30 ng/mL. As the reagent has been
diluted 1:3,300 in starvation medium, as control it has been used
starvation medium only. After 12 h, the expression level of mClover
fluorescent reporter was assessed with an epifluorescent microscope,
as well as quantified via flow cytometry.
2.2.5.10 Fluorescence imaging of living cells
Leica inverted epifluorescent microscope DM5500B equipped with
temperature control chamber system was used for documentation.
Acquisition parameters were kept constant between samples for
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comparison. Alternatively, Leica SP8 confocal laser scanning
microscope was used for high resolution image acquisition.
2.2.5.11 Cells freezing and thawing
For long-term storage, HEK293 cells were resuspended in complete
growth medium supplemented with 5 % (v/v) DMSO and transferred into
cryovials with screw cap. After gradual freezing at -80 °C in apposite
freezing containers, cells were transferred in liquid nitrogen. PAC2
zebrafish fibroblast cells were stored at -80 °C in Bambanker freezing
medium (NIPPON Genetics). All eukaryotic cell lines were thawed
quickly via immersion in 37 °C water bath. Right after thawing, cells were
resuspended in 10 mL complete medium to dilute the DMSO. After
centrifugation, cells were resuspended into fresh pre-warmed medium
and seeded on tissue culture plates.
2.2.6 Zebrafish husbandry and embryos manipulation
All experiments and ﬁsh maintenance were performed in accordance to
the European animal welfare standards and German legislation.
2.2.6.1 Zebrafish husbandry
Raising, spawning, and maintaining of zebrafish were performed as
described previously (Westerfield, 2000). After spawning, Zebrafish
embryos were maintained at 28 °C in 10 cm Petri dishes containing
Danieau 30 % solution (5.8 mM sodium chloride, 0.07 mM potassium
chloride, 0.04 mM magnesium sulfate, 0.06 mM calcium nitrate, 5 mM
HEPES (2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid), pH
7.2). Danio solution was replaced daily. Only the Zebrafish embryos
used for whole mount immunostaining experiments were maintained in
30 % Danieau solution supplemented with 0.003 % Propylthiouracil
(PTU) (Sigma, Steinheim, DE). PTU was added starting from 1 dpf.
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Zebrafish larvae designated to generate a new transgenic line were
raised to adulthood.
2.2.6.2 Zebrafish embryos microinjection
After spawning, fertilized eggs were collected and directly used for
nucleic acid microinjection. For DNA construct evaluation, expression
vector DNA was injected into zebrafish embryos at the single cell stage.
For zebrafish transgenic line generation, DNA vector containing an
expression cassette flanked by Tol2 inverted repeats sequences was
co-injected with Tol2 transposase mRNA into each zygote. Mix
preparation for injection is shown in Table 2.23. The Eppendorf Femtojet
Express Microinjector device was used for injection. Estimated volume
injected per cell: 2 nL.
Table 2.23: Zebrafish egg microinjection reaction mix
DNA injection RNA/DNAinjection
Final
concentration
Tol2 transposase
mRNA / 0.5 - 2 µL 25 ng/µL
Transposon-donor
plasmid 0.5 - 2 µL 0.5 - 2 µL 25 ng/µL
Red phenol 1 µL 1 µL 10 %
HPLC-grade water
(RNase-Free) 7 - 8.5 µL 5 - 8 µL
10 µL 10 µL
2.2.6.3 Zebrafish larvae spinal cord injury
Three days post-fertilization (3 dpf) zebrafish larvae were anesthetized
in 0.05 % tricaine (Sigma, Steinheim, DE) Danio 30 % solution for 10
min before wounding. Larvae were also kept in tricaine containing
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solution for the duration of the experiment. With a sterile syringe needle
(TERUMO 26g), a small transverse incision was applied to the dorsal
side of the fish at the high of the urogenital opening, aiming to cut the
spinal cord without cutting off the notochord and the dorsal aorta
underneath. Afterwards, larvae were transferred into Danieau 30 %
solution without anesthetic and incubated at 28 °C.
2.2.6.4 Fluorescence imaging of living zebrafish larvae
Zebrafish larvae between 2 and 5 dpf were anesthetized in 0.05 %
tricaine (Sigma, Steinheim, DE) Danio 30 % solution for 10 min prior
image acquisition. Leica epifluorescent stereo microscope (Leica
M205FA) was used for documentation. Acquisition parameters were
kept constant between samples for comparison. It should be noted that
cdh2r210pac mutants and tm101b pac mutants have fully comparable
phenotypes (Lele et al., 2002).
2.2.6.5 Embryonic zebrafish dissociation
Three days post-fertilization (3 dpf) zebrafish larvae were anesthetized
in 0.05 % tricaine (Sigma, Steinheim, DE) for 10 min prior dissociation.
Dissociation into homogeneous cell suspension was done as previously
described with minor modifications (Sassen et al., 2017; Russo et al.,
2018, JoVE). A minimum of 100 embryos were used per each
dissociation. Anesthetized 3 dpf embryos were transferred into a 6 cm
cell culture dish using a sterile Pasteur pipette. Embryos were
concentrated in a volume of few mL (max 2 mL).
Under a laminar flow clean bench embryos were de-yolked via
up-and-down pipetting through a 200 μL-pipette tip opening. De-yolked
embryos were pipetted into a sterile cell strainer placed in 70 % (v/v)
ethanol. After embryos complete immersion in ethanol for 5 sec, the cell
strainer containing embryos was transferred into a dish filled with
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Leibovitz's L-15 medium supplemented with 10 % FCS and 100 μg/mL
penicillin/streptomycin. Embryos were completely submerged in medium
to remove ethanol traces. All the embryos contained in the cell strainer
were than collected and transferred in a 1.5 mL sterile reaction tubes
and incubated in 1 mL solution of 4 mg/mL Collagenase Type II in
Leibovitz's L-15 medium supplemented with 10 % FCS and 100 μg/mL
penicillin/streptomycin. Dissociation reaction was incubated on a vertical
tube rotator with 30 revolutions per min for 45 min at RT. Dissociation
was promoted via up-and-down pipetting through progressively smaller
pipette tip opening (down to 10 µL tips). Generation of an almost
completely homogeneous single cell suspension was assessed with the
use of a microscope. Cell suspension was then filtrated through a 40
µm-net sterile cell strainer prior cultivation. Cells were counted and used
for different applications. The cell yield varied between 0.55 × 105 and
1.3 × 105 cells per 3 dpf larva. Variation can be attributed to the different
fish line growth speed, number of larvae used per each dissociation
reaction, and dissociation time.
2.2.7 Immunological methods
2.2.7.1 Blotting and staining of HEK293 cell lysate
Cell lysate of HEK293 cells transiently transfected with zCdh2-ECD-mFc
was used in this experiment. Sample was transferred from SDS gels
onto polyvinylidene fluoride (PVDF) membranes via semi-dry Western
blot using the Trans-Blot Turbo device (Bio-Rad, DE). Transfer was
performed under the following parameters: 0.4 A and 20 V for 30 min.
After protein transfer, PVDF membrane was blocked overnight at 4 °C in
blocking buffer (MPBST). Individually, each scFv-hFc antibody to zCdh2
was loaded onto pre-cut blot lanes. Antibody was used at a
concentration of 500 ng/mL in MPBST. After 1.5 h incubation, membrane
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was washed 3 times with PBST for 5 min each. Afterwards, goat
anti-human IgG (Fc-specific) alkaline phosphatase (AP)-conjugated
secondary antibody (Dianova 109-055-098, Hamburg, DE; 1:10,000)
was incubated for 1 h in MPBST. After washing three times with PBST
for 5 min each, the membrane was incubated in substrate buffer (100
mM Tris-HCl, 0.5 mM MgCl2, pH 9.5) for 5 min. Visualization was done
via incubation with substrate buffer with 1 % (v/v)
5-Brom-4-chlor-3-indolylphosphat (BCIP) and 1 % (v/v) nitro-blue
tetrazolium (NBT) (both from Applichem, Darmstadt, DE).
2.2.7.2 Titration ELISA
For scFv-Fc bivalent antibody binding characterization in ELISA, a
microtiter plate (High Binding Costar/Corning, New York, USA) was
coated overnight with 1 μg/mL (100 ng/well) antigen in PBS at 4 °C.
Zebrafish and human Cdh2-ECD-mFc antigens were used in this
experiment. An unrelated mIgG2a-Fc fused antigen was used as
negative control. Coated wells were blocked with MPBST (2 %
Milkpowder in PBS, 0.1 % Tween 20) for 1 h at RT, and then washed
three times with PBST (PBS, 0.05 % Tween 20). Soluble scFv-hFc
antibodies were diluted in 100 μL MPBST at a final concentration
ranging between 0.08 pM and 90.9 nM (for a total of 11 concentration
intervals differing by a factor of 4). Antibody solution was incubated for
1.5 h at room temperature (RT) in the antigen-coated wells. After
washing three times with PBST, bound scFv-hFc antibody was detected
with a goat anti human IgG (Fc-specific) horseradish peroxidase (HRP)
-conjugated secondary antibody (Sigma-A0170; 1:70,000). TMB
(3,3′,5,5′-tetramethylbenzidine) was used as HRP substrate for
visualization. The staining reaction was stopped by adding 100 μL 1 N
sulphuric acid. The absorbance at 450 nm and scattered light at 620 nm
were measured using a SUNRISE microtiter plate reader (Tecan,
Materials and Methods
62
Crailsheim, DE) and the 620 nm values were subtracted to calculate the
ELISA signal.
2.2.7.3 Domain mapping ELISA
ELISA assay was used to identify the single zCdh2 domains and domain
fragments recognized by the scFv-hFc antibodies. A microtiter plate
(High Binding Costar/Corning, New York, USA) was coated overnight at
4 °C with the mIgG2a-Fc fused recombinant zCdh2 antigens (Figure 2)
and unrelated mIgG2a-Fc fused antigen (CTR-) at a concentration of 2
μg/mL (200 ng/well) in PBS. Coated wells were blocked with MPBST for
1 h at RT. After washing three times with PBST, scFv-hFc antibodies
diluted in 100 μL MPBST were incubated in the antigen-coated wells for
1.5 h at RT. The wells were then washed three times with PBST. Bound
scFv-hFc antibody was detected with a goat anti human IgG (Fc-specific)
HRP-conjugated secondary antibody (Sigma-A0170; 1:70,000). The
visualization was performed as in 2.2.7.2.
2.2.7.4 Epitope mapping on PepSpot membrane
A PepSpot membrane covering the entire zCdh2-ECD1 by 29 peptides
was generated (JPT Peptide Technologies GmbH, Berlin, DE) to refine
the epitope of antibodies directed to this zCdh2 domain (aa 148-254).
Each peptide had a length of 15 aa. Peptide overlap was consisting of 11
aa, hence the offset was 4 aa. The PepSpot membrane was stained
accordingly to the manufacturer’s instructions. The membrane was
activated with methanol before washing with tris-buffered saline (TBS)
supplemented with 0.05 % Tween20 (TBST), and blocked with 2 % (w/v)
skim milk powder in TBST (MTBST). Primary scFv-hFc antibody to
zCdh2 was diluted in MTBST to a final concentration of 1 μg/mL and
incubated on the membrane overnight at 4 °C or 3 h at RT. Afterwards,
the membrane was washed three times with TBST for 5 min each,
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before incubation with goat anti human IgG (Fc-specific)
HRP-conjugated secondary antibody (Sigma-A0170; 1:70,000) for 2 h at
RT. Afterwards the membrane was washed 3x with TBST before
incubation with substrate solution (SuperSignal West Pico Plus
Chemiluminescent Substrate, Thermo Scientific, DE). ChemiDoc™ MP
Imaging System (Bio-Rad, München, DE) was used for image
acquisition.
2.2.7.5 Immunostaining of zebrafish or human cells
Independently from the source, cell for flow cytometry were always
detached from the respective culture plate with non-enzymatic methods,
mechanically, to preserve the integrity of surface antigens. A total of
4–5x105 cells/sample were aliquoted into FACS plates (Eppendorf
Deepwell plates, Protein LoBind, 96 wells, Hamburg, DE). Cells were
pelleted by centrifugation (350 ×g, 5 min) at 4 °C. Supernatant was
removed without disturbing the pellet. Cells were resuspended in
ice-cold FACS-buffer (0.5 % BSA, 5 mM EDTA in PBS). Each
centrifugation step was performed at 4 °C, while every incubation on ice.
Primary antibody was diluted in FACS-buffer at the concentration
specified for every experiment and incubated on ice for 1 h. Afterwards,
cells were washed twice with FACS-buffer. Appropriate fluorescently
coupled secondary antibody were incubated 30 min on ice in the dark
(see table 2.12). Cells were washed twice, than filtered through CellTrics
50 μm filters (Sysmex, Norderstedt, DE). Flow cytometry analysis
measurements were done with an SH-800 cell sorter (Sony, San Jose,
CA, USA) and a CytoFLEX device (Beckman Coulter, Brea, CA, USA). A
488 nm laser was used to excite GFP or FITC. Emission was detected
with a 525 ± 25 nm optical filter or a 525 ± 40 nm filter, respectively when
using the SH-800 cell sorter or the CytoFLEX device (FITC-channel).
The use of the SH-800 cell sorter (Sony, San Jose, CA, USA) was
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possible thanks to the support of the instrument responsible person,
Fahr Wieland.
APC-coupled antibody was detected in the range 665 ± 30 nm (SH-800
cell sorter) or 660 ± 20 nm (CytoFLEX device) for excitation with a 638
nm laser. Per each sample 105 events were analyzed. Forward scatter
(FSC) vs backward scatter (BSC) dot plot served to gate alive cells,
categorized as larger and less granular in average compared to dead
cells. FSC signal height (FSC-H) plotted against FSC area (FSC-A)
allowed to distinguish between single cells and doublets. Cdh2-GFP
cells (zf516vTg line derived) were mostly found as doublets despite the
presence of 5 mM EDTA in solution and the cell filtration step. This
information was used to adjust the gating in order to enrich the
Cdh2-positive cell population. For all the flow cytometry experiments on
cell lines alive single cells were used for analysis.
2.2.7.6.1 Whole mount zebrafish immunofluorescent staining
GFP-positive zf516 Tg, and zCdh2 pac mutants larvae at 3 dpf were
incubated 10 min in 0.05 % tricaine solution (Sigma, Steinheim, DE).
After anesthesia, larvae were fixed and permeabilized in a 4 %
paraformaldehyde (Merck, Darmstadt, DE) solution containing 0.1 %
Triton X-100 (Bio-Rad, Münich, DE) in PBS for 3 h at 4 °C. Sample was
rotated during all incubation and washing steps, with the exception of the
acetone antigen retrieval one. Fixed tissue was rinsed for 10 min with
PBS plus 0.1 % Triton X-100. Subsequent incubation for 15 min at
−20 °C in ultrapure acetone served for antigen retrieval. Samples were
then washed twice for 10 min in PBS supplemented with 1 % BSA, 1 %
Triton X-100 and 1 % DMSO. Samples were blocked with 5 % goat
normal serum (Vector labs/BIOZOL, Eching, DE) and 1 % BSA in PBS
plus 1 % Triton X-100 and 1 % Dimethyl sulfoxide (DMSO), 1 h at RT.
Afterwards, primary antibody solution was incubated overnight at 4 °C in
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PBS plus 1 % BSA, 0.1 % Triton X-100 and 1 % DMSO. Rabbit
polyclonal antibody GTX125885 α-zCdh2 was diluted 1:100 or 1:500 (8
μg/mL or 1.6 μg/mL respectively). ScFv-hFc antibodies were diluted to a
final concentration of 10 μg/mL. After primary antibody incubation,
samples were washed four times for 10 min each with PBS containing
0.1 % Triton X-100. Secondary antibody solution prepared in PBS plus
1 % BSA, 0.1 % Triton X-100, and 1 % DMSO was incubated 3 h at RT.
Depending on the primary antibody, goat α-rabbit IgG (H + L-specific)
Cy3-conjugated (Dianova 111-136-144, Hamburg, DE; 1:100) or rat
α-human IgG (Fc-specific) APC-conjugated (Biolegend/BIOZOL
M1310G05, Eching, DE; 1:100) secondary antibody were used.
Afterwards, washing step was repeated as previously described. The
two different fish lines were stained in the same reaction tube by each
antibody to respect best comparison criteria. Morphological and
fluorescent properties of the two lines allow for discriminating them after
the staining during the imaging. GFP-positive zf516 Tg and zCdh2 pac
mutants larvae after immunostaining were mounted in 1.2 % ultra-low
melting agarose. A confocal laser scanning microscope Leica SP8
(Leica microsystems, Wetzlar, DE) was used for image acquisition with
the help of Dr. Theisen Ulrike. GFP and APC were excited by a Argon
laser (488 nm) and a 633 nm HeNe laser respectively. Multiple z-Stacks
spanning the whole tissue of interest were acquired. Image analysis was
performed as described in the related paragraph of Bioinformatics
methods (2.2.8.4).
2.2.8 Bioinformatics methods
2.2.8.1 In silico cloning
Using the bioinformatics software Geneious 4.8.5, every DNA cloning
experiment was simulated in silico prior wet lab execution. Newly
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generated vectors were sequenced and related results used to verify the
exactness of the cloning based on the in silico design. Oligonucleotide
primers were also designed using this bioinformatics platform. Primer
annealing temperature, risk of dimer formation, 3’-extension, and
presence of hairpins were verified using the online tool Promix, from the
CRIBI Genomics Group University of Padua.
2.2.8.2 Bioinformatics analysis of the antibody sequences
VBASE2 Fab Analysis Tool (Mollova et al., 2010) was used for the scFv
antibody sequence analysis to identify heavy and light chain variable
region subfamilies.
2.2.8.3 Protein sequence characterization
Estimated protein molecular weight was obtained with the bioinformatics
software Geneious 4.8.5, which was also used to calculate their molar
extinction coefficient.
2.2.8.3 Sequence and structure analysis of zCdh2 mapped epitopes
SWISS-MODEL online platform (Arnold et al., 2006; Guex et al., 2009;
Kiefer et al., 2009; Biasini et al., 2014) was used to model the the
zCdh2-ECD (Uniprot: Q90275, aa 148-711) on the base of the crystal
structure of the murine Cdh2-ECD (pdb 3Q2W) (Harrison et al., 2011).
Amino acid similarity between the two extracellular domain is 75.4 %,
80.4 % when considering only domain 1. The epitopes of antibody
SH1352-B11 and SH1352-C6, discovered on PepSpot membrane
analysis, have been represented on the model of zCdh2-ECD1 using the
software for protein structure analysis PyMol v1.3.
2.2.8.4 Zebrafish whole mount images processing
Leica Application Suite X (Las X) software or the Grid/Collection
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stitching plugin of ImageJ (Schneider et al., 2012) were used to stitch
frames composing the whole mount. Las X, ImageJ, and Adobe
Photoshop were used for images processing. Images from larvae
stained by the same antibody in an individual reaction tube were
processed using identical parameters for optimum comparison
conditions.
2.2.8.5 Flow Cytometry data analysis and plots generation
Display of flow cytometry data and respective analysis was performed
using SH-800 software (Sony, San Jose, CA, USA), CytExpert 1.2
software (Beckman Coulter, Brea, CA, USA), or Weasel v3.3.
2.2.8.6 scFv-hFc antibody EC50 value determination
Apparent scFv-hFc antibody affinity was estimated by ELISA-based
determination of the EC50 value. In the titration ELISA experiment
(Figure 4), EC50 is defined as the concentration of antibody where half
of the maximum signal is reached. The maximum signal is reached
when antibody binding to the antigen is in saturation. Therefore, EC50
could be calculated only when the titration curve spanned from antibody
concentration values that corresponded to absence of binding, to
concentration values that corresponded to saturation of the binding
towards the antigen. These EC50 values were calculated using the
equation for 4 parameter logistic (4PL) symmetrical sigmoid curve fit
(Sigmoidal, 4PL, X is log(concentration)) available from the interpolation
analysis tool of the bioinformatics software GraphPad Prism 6.
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3. Results
3.1. Generation and characterization of antibodies to zCdh2
3.1.1. Production of recombinant zCdh2-ECD antigens
For antibody selection and for subsequent epitope mapping,
recombinant versions of zebrafish Cdh2 were produced. DNA encoding
the zebrafish Cdh2 extracellular domain was amplified via PCR from
zebrafish AB strain cDNA. To generate Fc-fused antigens for antibody
selection and epitope determination, eight variants including the whole
zCdh2 extracellular domain (zCdh2-ECD), as well as seven truncated
recombinant variants of the same molecule, were cloned into
pCSE2.6-mIgG2a-Fc-XP mammalian expression vectors (Miethe et al.,
2015; Froude et al., 2017) (Figure 2). One recombinant variant
(zCdh2-ECD1-2) was cloned as well into the pCSE2.6-hIgG1-Fc-XP
vector (encoding for a human Fc part) to generate the antigen suitable
for antibody selection (Figure 2). HEK293-6E cells and Protein A affinity
chromatography purification allowed the production of the recombinant
Fc-fusion proteins. SDS-PAGE analysis and Coomassie blue staining
confirmed the purity of the antigen preparation (Figure 3) and the
expected relative molecular mass of the antigens (Table 3.1).
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Table 3.1: Yields, molecular mass, and N-glycosylation of the
Fc-fused zCdh2-ECD domains and domain fragments
Zebrafish Cdh2 domains
and recombinant
fragments
Conc.
(mg/mL)
mg/L
(protein/cultu
re volume)
Predicted
molecular
mass (kDa)
N-glycosyl.
sites
zCdh2-ECD (aa
148-702)-mIgG2a-Fc 0.23 34.5 101.1 2
zCdh2-ECD1-2 (aa
148-369)-mIgG2a-Fc 0.34 51.0 50.3 1
zCdh2-ECD1-2 (aa
148-369)-hIgG1-Fc 0.55 82.5 50.5 1
zCdh2-ECD1 (aa
148-254)-mIgG2a-Fc 0.53 79.5 37.8 0
Cdh2-ECD2 (aa
255-369)-mIgG2a-Fc 0.22 33.0 38.1 1
zCdh2-ECD-aa
148-207-mIgG2a-Fc 0.58 87.0 32.2 0
zCdh2-ECD-aa
195-273-mIgG2a-Fc 0.13 20.2 34.4 0
zCdh2-ECD-aa
263-324-mIgG2a-Fc 0.52 78.0 32.2 0
zCdh2-ECD-aa
315-369-mIgG2a-Fc 0.05 7.5 31.5 1
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Fig. 2: zCdh2-ECD derived antigens fused to human/mouse Fc-part.
Zebrafish Cdh2 extracellular region and single domain fragments were
generated as mouse or human Fc-fusion antigens. Amino acid numbering
according to Uniprot Q90275.
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Fig. 3: Mouse Fc-fusion Cdh2-ECD derived antigens purity evaluation.
Coomassie stained 12 % SDS-PAGE-gel chromatography of purified mouse
IgG2aFc-fused zCdh2-ECD and derived fragments. Purified zCdh2 derived
antigens are assumed to appear as single or double band dependent on the
glycosylation state of the molecule. N-glycosylation is expected at residues: 260,
312, 389, 442, 559, 609, 638, and 679; as such it will be more visible for some
antigens than others. M, marker.
3.1.2. Generation of human scFv antibodies to zCdh2
The naive human antibody gene libraries HAL9 and HAL10 were used
as starting material for the generation of recombinant scFv antibody
fragments to zCdh2-ECD1-2 via phage display. zCdh2-ECD1-2-hFc
recombinant protein immobilized on microtiter plates was used as
antigen for antibody selection, while an unrelated hFc-fused antigen was
used for negative selection, by means of library preincubation and
competition, in each round of antibody selection (panning round).
After three panning rounds, 92 E. coli clones were randomly picked and
cultivated to produce soluble scFv fragments. Their cultivation
supernatants were individually tested in screening ELISA for binding to
immobilized zCdh2-ECD1-2-hFc or the unrelated hFc-fused antigen.
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Out of 92 tested scFv’s, 21 bound to the zCdh2-ECD1-2-hFc but not to
the negative control antigen. The DNA encoding each selected scFv
clone was isolated and treated with the restriction enzyme BstNI. Twelve
different restriction patters were identified and the corresponding scFv
DNA sequence of one clone representative for each pattern was
determined. The sequencing result confirmed the selection of 11 unique
human mAb sequences. Analysis of these 11 scFv sequences using the
VBASE2 Fab Analysis Tool (Mollova et al., 2010) showed their high
genetic diversity in respect of their heavy and light chain variable region
subfamilies origin (Table 3.2).
Table 3.2: recAb heavy chain (VH) and light chain (VL) variable
region subfamilies.
Gene segments: V (variable region), D (diversity region), J (joint region)
Antibody
clone VH - V VH - D VH - J VL - V VL - J
SH1352-A3 IGHV3-33*01 IGHD2-21*02 IGHJ4*02 IGLV3-19*01 IGLJ3*02
SH1352-B11 IGHV3-33*01 IGHD6-13*01inv IGHJ4*02 IGLV6-57*01 IGLJ3*02
SH1352-C6 IGHV5-51*01 IGHD1-26*01inv IGHJ4*02 IGLV3-19*01 IGLJ3*01
SH1352-D7 IGHV3-33*01 IGHD1-1*01inv IGHJ6*02 IGLV1-47*01 IGLJ3*02
SH1352-E1 IGHV3-33*01 IGHD6-19*01 IGHJ4*02 IGLV6-57*01 IGLJ3*02
SH1352-E11 IGHV1-46*03 unclear IGHJ4*02 IGLV1-47*02 IGLJ3*01
SH1352-F4 IGHV1-18*01 IGHD2-21*02inv IGHJ5*02 IGLV2-14*01 IGLJ3*01
SH1352-F6 IGHV3-33*01 IGHD1-26*01 IGHJ4*03 IGLV1-47*02 IGLJ3*02
SH1352-F9 IGHV1-2*02 IGHD2-15*01 IGHJ1*01 IGLV2-8*01 IGLJ1*01
SH1352-G9 IGHV1-8*01 IGHD5-5*01 IGHJ4*02 IGLV3-19*01 IGLJ3*01
SH1352-G12 IGHV5-a*03 IGHD5-18*01 IGHJ4*02 IGLV1-44*01 IGLJ3*02
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3.1.3. Production of bivalent human antibodies (scFv-hFc)
DNA encoding each unique scFv antibody was subcloned into the
mammalian expression vector pCSE2.6-hIgG1-Fc-XP to produce mAbs
in the scFv-Fc format by addition of the human IgG1-Fc moiety.
HEK293-6E cells were transfected with the scFv-hFc antibody
expression vectors for transient antibody production. After about one
week, Protein A affinity chromatography purification of cultivation
supernatant yielded highly purified scFv-hFc antibodies with yields
ranging between 12 mg/L and 124.8 mg/L (Table 3.3). ScFv-hFc
antibody purity was confirmed by SDS-PAGE under reducing conditions
and Coomassie blue staining (data not shown).
Table 3.3: Yields of scFv-hFc antibodies
Antibody clone Concentration(mg/mL)
mg/L (protein/culture
volume)
SH1352-A3-hIgG-Fc 0.26 30.0
SH1352-B11-hIgG-Fc 0.10 15.0
SH1352-C6-hIgG-Fc 0.08 12.0
SH1352-D7-hIgG-Fc 0.38 57.0
SH1352-E1-hIgG-Fc 0.10 15.0
SH1352-E11-hIgG-Fc 1.56 124.8
SH1352-F4-hIgG-Fc 0.27 40.5
SH1352-F6-hIgG-Fc 0.27 40.5
SH1352-F9-hIgG-Fc 0.13 19.5
SH1352-G9-hIgG-Fc 0.73 109.5
SH1352-G12-hIgG-Fc 0.29 43.5
3.1.4. scFv-hFc antibody binding to recombinant zCdh2-ECD
Titration-ELISA on coated antigen zCdh2-ECD-mFc was used to
determine the binding of the purified scFv-hFc antibodies to the whole
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zCdh2 extracellular domain. The apparent EC-50 obtained in this assay,
despite it does not allow for determining absolute antibody affinity, it
permits to generate an affinity-based ranking of the tested antibodies.
The scFv-hFc antibodies were tested in a concentration series ranging
from 0.08 pM to 90.9 nM (Figure 4). All the antibodies originally
generated against the zCdh2-ECD1-2 bound to the recombinant antigen
zCdh2-ECD-mFc. Antibody SH1352-C6-Fc showed the strongest
binding in ELISA, while SH1352-G12-Fc showed the weakest binding,
as shown by the apparent antibody affinity estimated by ELISA-based
determination of the EC50 values (Table 3.4). No one of the tested
antibodies showed reactivity to the unrelated mFc-fused antigen used as
CTR-.
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Fig. 4: scFv-hFc mAbs binding to zCdh2-ECD coated Ag in ELISA.
Titration ELISA to evaluate the binding of scFv-hFc α-zCdh2-ECD mAbs to the
recombinant antigens zCdh2-ECD-mFc or hCdh2-ECD-mFc. An unrelated
mFc-fusion protein was used as negative control. 100 ng antigen per well were
immobilized and incubated with 0.08 pM to 90.9 nM scFv-hFc mAbs.
Table 3.4: scFv-hFc mAbs apparent affinity expressed as
ELISA-based EC50 values
Antibody clone EC50 [nM] on zCdh2-ECD EC50 [nM] on hCdh2-ECD
SH1352-A3-hIgG-Fc 3.90 -
SH1352-B11-hIgG-Fc 1.12 0.62
SH1352-C6-hIgG-Fc 0.37 -
SH1352-D7-hIgG-Fc 0.67 Not quantifiable
SH1352-E1-hIgG-Fc 0.85 0.49
SH1352-E11-hIgG-Fc 0.70 -
SH1352-F4-hIgG-Fc 3.25 -
SH1352-F6-hIgG-Fc 0.64 2.45
SH1352-F9-hIgG-Fc 1.12 -
SH1352-G9-hIgG-Fc 0.56 -
SH1352-G12-hIgG-Fc Not quantifiable -
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3.1.5. ScFv-hFc antibodies bind to zebrafish primary cells
Whether the new monoclonal human scFv-hFc antibodies can bind to
native fish Cdh2 was assessed by flow cytometry analysis of living
zebrafish primary cells derived from 3 dpf larvae. To unequivocally
assess antibody specificity, three different zebrafish lines were used in
the experiment: Wt, Cdh2-GFP-RFP (line zf516 Tg (TgBAC
(cdh2:cdh2-sfGFP-TagRFP, crybb1:ECFP))), and Cdh2 loss of function
parachute (pac) mutant (pacR2.10 mutant) (Lele et al., 2002; Revenu et
al., 2014). In the zf516 Tg line, Cdh2-positive cells express the construct
zCdh2-GFP-RFP, while eCFP is expressed in the lens to enable easy
screens of transgene expressing carriers during early stages of
development when the zCdh2-GFP-RFP is not yet detectable. In
contrast to other pac mutants, pacR2.10 originates from a ‘G’ to ‘A’
mutation in the splicing donor cite (GT) of an intron at position +48 of the
Cdh2 coding sequence. The consequent incorrect splicing does not
allow the formation of correct transcripts with resulting absence of even
partial protein product translation (Lele et al., 2002). In this parachute
line, no Cdh2 is expressed, so that any binding detected on this line has
to be considered unspecific.
In this assay only the GFP fluorescence was specifically acquired to
identify Cdh2-positive cells, as no yellow-green laser for RFP excitation
was used, neither filters for the detection of eventual RFP emission.
Thanks to the GFP reporter expression in the Cdh2-GFP-RFP zf516 Tg
line, back-gating of the Cdh2-positive cells in the FSC-A - FSC-H plot
allowed to enrich the Cdh2-positive cells for a better visualization of the
antibody staining. An antibody has been classified as specific and
non-cross-reactive when meeting the following two conditions: absence
of staining on the pac embryo-derived cells and positive staining of the
GFP positive cells (zf516 Tg line). The scFv-hFc antibodies were tested
at the concentration of 10 µg/mL.
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Of the 11 antibodies tested (Figure 5), 8 showed reactivity in this assay,
while SH1352-E1, -E11, and -G12 did not stain any cell from any of the
used samples. Of the 8 reactive antibodies 6 could be classified as fully
specific to the target accordingly to the above mentioned parameters:
SH1352-A3, -B11, -D7, -F4, -F9, and -G9. The binding profile of the 2
antibodies which showed cross-reactivity was different. SH1352-F6, in
addition to the binding of Cdh2-GFP cells, showed a minimal
cross-reactivity to a small Cdh2-negative cell population, observable in
null-mutant derived cells.
On the contrary, SH1352-C6 unwanted cross-reactivity was more
pronounced and clearly identified as presence of staining in pac mutant
derived cells, as well as staining of GFP-negative cells from the zf516 Tg
sample (Cdh2-GFP line). Flow cytometric analysis was then used to
compare the specificity profile of the commercial antibody to zCdh2-ECD
(GTX125885) with that of scFv-hFc SH1352-G9. GTX125885 was used
in several previous studies to map the expression of Cdh2 (Tuttle et al.,
2014; Xing et al., 2015; Han et al., 2016; Mochizuki et al., 2017; Gays et
al., 2017; Powell et al., 2018) and was the only α-zCdh2 antibody
commercially available at the time. Even at very high concentration (up
to 50 µg/mL), no reactivity of SH1352-G9 was found on homozygous
pac mutant cells. On the contrary GTX125885 stained 45 % of cells
known not to express Cdh2 (Figure 6). GTX125885 stained also 57 % of
the Wt and 65 % of the zf516 Tg line derived cells, where only ~30 % are
GFP-positive. GTX125885 as well as our highly specific scFv-hFc
antibodies SH1352-B11, -D7, -F4 and -G9, could not stain a low
percentage of Cdh2-GFP-RFP cells from zf516 Tg larvae.
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Fig. 5: scFv-hFc specificity assessment in flow cytometry.
Antibody binding to endogenous zCdh2 on zebrafish primary cells was
evaluated by immunofluorescent staining and flow cytometry analysis. Living
zebrafish primary cells were derived from three different fish lines at 3 dpf:
zf516Tg (zCdh2-GFP fusion) in the left panels, zCdh2 homozygous pac mutant
in the middle panels, and Wt in the right panels. y-axis: antibody staining
(APC-channel), x-axis GFP signal from zCdh2-GFP fusions. All monoclonal
antibodies were used at 10 µg/mL. α-hIgG: secondary antibody control.
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Fig. 6: GTX125885 Ab and SH1352-G9 mAb binding comparison in FACS.
Binding to endogenous zCdh2 on zebrafish primary cells was evaluated by
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immunofluorescent staining and flow cytometry analysis. Living primary cells
were derived from three different fish lines at 3 dpf as described in figure 5.
α-rIgG: secondary antibody control for GTX125885. α-hIgG: secondary antibody
control for SH1352-G9. Note the concentration differences between GTX125885
and SH1352-G9.
3.1.6. ScFv-hFc antibodies identify Cdh2 in zebrafish whole
mounts
The scFv-hFc antibodies specifically recognizing zCdh2 on zebrafish
primary cells (SH1352-B11, -D7, -F4, -G9) were used for whole mount
immunofluorescent staining of 3 days old larvae after fixation. Direct
comparison of the antibody staining with the zCdh2 expression pattern
was achieved using the zf516 Tg larvae, which express
zCdh2-GFP-RFP under the control of the original zCdh2 promoter (note:
only GFP fluorescence was acquired). To assess antibody specificity,
pac mutant larvae (zCdh2 null mutant) were included in the experiment
as well. For a more appropriate comparison of the results, pac mutant
and zf516 Tg larvae were stained in the same reaction tube by each
antibody. The different larvae origin was easily discriminated by their
different morphology, and by the presence/absence of GFP
fluorescence. All the images acquired were processed equally, and
APC-conjugated secondary antibody was used for detection. APC
emission range (emission max at 660 nm) allowed us to avoid signal
spillover from the GFP-RFP channels (emission max respectively at 510
nm and 588 nm). After the staining, images were recorded from whole
larvae, or specific tissues and fish body parts, always in lateral view, via
confocal microscopy.
SH1352-G9 antibody staining fully overlapped with the expression
pattern of the zCdh2-GFP-RFP in zf516 Tg larvae (Figure 7C and 8C)
and did not show any reactivity on pac mutant larvae (Figure 7D and 8D).
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The absence of antibody staining in the lens is explained by the fact that
the lens do not express zCdh2-GFP-RFP, but the eCFP lens-marker
(crybb1:ECFP). The low eCFP excitation by the 488 nm laser is
considered to be compensated by the high protein density in lens fiber
cells and by the fact eCFP has bimodal emission and excitation spectra.
SH1352-B11 and SH1352-F4 scFv-hFc antibodies also specifically
recognized the antigen in whole mount immunofluorescent staining
(Figure 9), but signal intensity was lower than the one of SH1352-G9
staining. SH1352-D7 antibody staining failed to fully recapitulate the
endogenous zCdh2 expression pattern in this particular IHC assay
(Figure 9).
SH1352-G9 and GTX125885 specificity profiles were further compared
in this IHC assay, recapitulating the results obtained by comparing the
activity of these two antibodies in flow cytometry on primary cells. While
SH1352-G9 did not bind to the homozygous pac mutant larvae,
GTX125885 stained several tissues despite the complete absence of
Cdh2 expression in the parachute line (Figures 7B and 8B).
Consequently it bound to structures which did not match the zCdh2
fluorescence pattern in the zf516 Tg fish line (Figures 7A and 8A).
Interestingly, despite its polyclonal nature and its tendency to bind
ectopically, GTX125885 failed to stain the spinal cord, where Cdh2-GFP
is highly expressed. It therefore elicited both false positive and false
negative reactivity. On the contrary, SH1352-G9 correctly bound to this
structure.
The secondary antibody control sample showed none of the unspecific
staining observed with GTX125885, thus unspecific staining results
cannot be attributed to the secondary antibody used in this assay
(Figure 10).
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Fig. 7: GTX125885 Ab and SH1352-G9 mAb binding comparison in whole
mount IHC.
Confocal images from zf516 Tg (Cdh2-GFP) or Pac mutant (not expressing
Cdh2) 3 dpf larvae stained respectively with A, B) GTX125885 antibody (1.6
µg/mL) or C, D) SH1352-G9 scFv-hFc (10 µg/mL). Cyan = GFP channel
(zCdh2-GFP fusion protein expression); Magenta = antibody staining.
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Fig. 8: GTX125885 Ab and SH1352-G9 mAb whole mount staining details .
Confocal images show zf516 Tg (Cdh2-GFP) and Pac mutant larvae stained as
described in Fig. 7.
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Fig. 9: RecAbs specificity assessment in whole mount IHC.
A) SH1352-B11, -D7, and -F4 scFv-hFc’s binding comparison on zebrafish
zf516 Tg (Cdh2-GFP) and B) homozygous pac mutant larvae fixed at 3 dpf. All
the scFv-hFc mAbs were tested at the concentration of 10 μg/mL. Cyan = GFP
(zCdh2 distribution); Magenta = antibody staining.
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Fig. 10: Whole mount zebrafish IHC secondary antibody controls.
Confocal imaging of 3 dpf larvae A) trunk and B) hindbrain region, after staining
with α- human IgG and α-rabbit IgG secondary antibodies respectively APC- or
Cy3-conjugated. These controls refer to the results shown in figures 7, 8, and 9.
Cyan = GFP (zCdh2 distribution); Magenta = antibody staining.
3.1.7. Some scFv-hFc antibodies bind to human Cdh2 and zCdh2
The ORF encoding human Cdh2-ECD was amplified from HEK293 cells
cDNA via PCR and cloned into the pCSE2.6-hIgG-Fc-XP vector for
production as mFc-fused antigen. Cloning, production, and purification
was performed following the same procedure described for the zCdh2
antigens production (see paragraph 3.1.1.). To assess antibody
cross-binding to the extracellular domain of human Cdh2, every antibody
was tested in titration ELISA on coated hCdh2-mFc antigen (as
previously described, see paragraph 3.1.4.).
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An unrelated mFc-fused antigen was used as negative control. Of the
antibodies tested, four scFv-hFc recognized the soluble hCdh2-ECD
(SH1352-B11, -D7, -E1, F6), of which only two bound the antigen with
comparable affinity to the human and zebrafish variants of the Cdh2
(Sh1352-B11, -E1) (Figure 4).
To assess whether the binding of Cadherin2 on cells matches the
binding determined in ELISA, HEK293 human cell lines, known to
express Cdh2, where used in flow cytometry antibody binding analysis.
All the antibodies positive on hCdh2-ECD in ELISA were also positive on
cells, with the exception of SH1352-D7. The antibody SH1352-C6 bound
to HEK293 cells (Figure 11), while it did not recognized the human Cdh2
in ELISA (Figure 4).
Fig. 11: Evaluation of scFv-hFc Abs binding to HEK293 cells.
Immunofluorescent staining and flow cytometry analysis of human cell lines with
α-zCdh2 scFv-hFc antibodies. scFv-hFc mAbs were used at 10 µg/mL.
3.1.8. Epitope mapping of human anti-zCdh2 antibodies
The binding regions recognized by the different scFv-hFc antibodies
were assessed via ELISA on zCdh2-ECD fragments. As
zCdh2-ECD1-2-hFc was the antigen used for antibody selection, the
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fragments designed for epitope analysis were all representing a region
of zCdh2 included within the first two extracellular domains of the
antigen target: zCdh2-ECD1-mFc (aa 148-254), zCdh2-ECD2-mFc (aa
255-369), zCdh2-148-207-mFc, zCdh2-195-273-mFc,
zCdh2-263-324-mFc or zCdh2-315-369-mFc (Figure 2). SH1352-A3
recognized domain 2 (ECD2), while all the remaining antibodies bound
to domain 1 (ECD1). Binding analysis using smaller fragments derived
from zCdh2-ECD1 and -ECD2 allowed us to further narrow down the
epitope containing regions recognized by 6 of the 11 antibodies (Table
3.5).
Table 3.5: scFv-hFc mAbs binding to zCdh2 single domains and
domain fragments.
Antibody
clone
zCdh2-E
CD (aa
148-702)
zCdh2-E
CD1 (aa
148-254)
zCdh2-E
CD2 (aa
255-369)
zCdh2-E
CD- aa
148-207
zCdh2-EC
D- aa
195-273
CTR-
Minimal
epitope
region bound
in ELISA
SH1352-A3 100 % 0.68 % 105.30 % 0.71 % 115.30 % 3.98 % aa 255-273
SH1352-B11 100 % 99.54 % 2.19 % 0.69 % 96.12 % 4.47 % aa 195-273
SH1352-C6 100 % 101.28 % 2.57 % 97.06 % 0.98 % 3.11 % aa 148-207
SH1352-D7 100 % 105.45 % 2.33 % 0.62 % 0.89 % 2.47 % zCdh2-ECD1
SH1352-E1 100 % 103.00 % 2.36 % 0.71 % 93.37 % 2.51 % aa 195-273
SH1352-E11 100 % 112.00 % 3.02 % 1.23 % 106.22 % 2.42 % aa 195-273
SH1352-F4 100 % 112.01 % 2.18 % 0.61 % 0.58 % 1.92 % zCdh2-ECD1
SH1352-F6 100 % 103.48 % 2.02 % 0.68 % 4.29 % 2.19 % aa 195-273
SH1352-F9 100 % 101.64 % 2.01 % 0.67 % 0.67 % 2.47 % zCdh2-ECD1
SH1352-G9 100 % 99.50 % 2.03 % 0.53 % 0.56 % 1.96 % zCdh2-ECD1
SH1352-G12 100 % 130.19 % 2.45 % 0.55 % 0.51 % 2.45 % zCdh2-ECD1
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To determine the bound epitope more exactly, the four antibody-clones
specific in flow cytometry on primary zebrafish cells (SH1352-B11, -D7,
-F4, -G9), as well as the unspecific SH1352-C6, were analyzed with
single amino acid side chain resolution by PepSpot membrane binding
assay (peptide length: 15 aa; peptide overlap: 11 aa). Only SH1352-B11
and SH1352-C6 reacted with the PepSpot membrane (Figure 12),
indicating a linear continuous peptide epitope structure. The two
epitopes were visualized on a zCdh2-ECD1 model structure (Figure 13)
generated with SWISS-MODEL (Arnold et al., 2006; Guex et al., 2009;
Kiefer et al., 2009; Biasini et al., 2014) exploiting the high (80.4 %)
sequence similarity to the mouse zCdh2-ECD1, the crystal structure of
which is known (PDB: 3Q2W) (Harrison et al., 2011).
To analyze why only some antibodies reacted with the zCdh2 peptide,
the binding of the five scFv-hFc’s to denatured protein was analyzed in
western blot after SDS-PAGE of total cell lysate of HEK293 cells
overexpressing zCdh2-ECD-mFc. All tested antibodies recognized the
target prepared in reducing conditions (Figure 14). At the tested antibody
concentration, SH1352-B11 and -C6 seemed to bind better to the target
in this assay, and allowed to detect a higher molecular mass band
presumably representing the glycosylated form of the protein.
SH1352-C6 detected additional proteins than zCdh2, which is in line
with the flow cytometry data which show the tendency of this antibody
towards broader reactivity.
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Fig. 12: SH1352-B11 and -C6 mAbs epitope mapping.
Epitope determination of the SH1352-B11 and SH1352-C6 mAbs on PepSpot
membranes covering the entire zCdh2-ECD1 domain in 29 spots of 15aa
peptides with 11 residues overlap.
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Fig. 13: SH1352-B11 and -C6 epitopes on zCdh2 model structure.
zCdh2-ECD1 model structure was obtained by homology modelling based on
the mouse Cdh2 crystal structure 3Q2W, and represented using PyMol.
SH1352-B11 and SH1352-C6 mAbs epitopes are indicated respectively in blue
or green. Upper panels: α-helix in cyan, ß-sheets in red, and loops in magenta.
Side chains are shown uniquely for the epitope regions and the related solvent
accessible surface respectively in blue or green. Lower panels: solvent
accessible surface. Of all the SH1352-B11 epitope residues, 1 belongs to a
ß-sheet and 10 to a loop, while for SH1352-C6 6 belongs to a ß-sheet and 4 to a
loop. The estimated epitope area is of 1,658.301 Å2 and 2,087.116 Å2
respectively for SH1352-B11 and SH1352-C6. zCdh2-ECD1 total area is
estimated in around 7,721.633 Å2. Numbering of the amino acids responsible for
lateral association of the cadherin dimers on the cell surface is based on the
homologous mouse Cdh2 positions.
Fig. 14: Assessment of mAbs binding to zCdh2 in western blot.
scFv-hFc mAb to zCdh2 binding to immunoblots of total cell lysate of HEK293
cells expressing zCdh2-ECD-mFc (separated by SDS-PAGE under reducing
conditions).
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3.2. ER intrabody mediated knockdown in vitro
3.2.1. ER intrabody mediated retention works in zebrafish cells
Despite the expression of KDEL receptors in zebrafish has been
described (Thisse et al., 2001), an ER intrabody retention in zebrafish
has not been demonstrated so far. For this purpose, the knockdown
activity of a previously well validated ER intrabody to mouse p75 (Zhang
et al., 2012) was tested in zebrafish PAC2 cells after transient
co-transfection with an expression vector containing its mouse antigen
target fused to YFP. As mouse p75 extracellular domain shows at most
43.5 % amino acid similarity with its zebrafish hortologue (GQ983383.1),
the risk of cross-binding is considered to be excluded. The unrelated
ER intrabody α-phOx-KDEL binding to the small molecule
phenoxazolone, which is not present in living cells, was used as
negative control. Surface levels of transfected p75 were determined in
flow cytometry 24 hours post transfection (hpt) in the presence of either
α-p75 (SH325-G7-KDEL) or α-phOx ER intrabodies (Figure 15).
In the p75-YFP - α-phOx-KDEL sample, every cell expressing the
antigen target fused to YFP (YFP-positive cells) could be stained on the
surface with the use of a second α-p75 antibody (APC-positive cells)
binding to an epitope not overlapping with that of the intrabody. On the
contrary, in the presence of the ER intrabody specific to mouse p75, a
cell population became evidently characterized by the expression of the
target (YFP-positive), but its absence from the cells surface. This
demonstrated for the first time an ER intrabody mediated knockdown in
zebrafish.
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Fig. 15: ER intrabody knockdown of mouse p75 in PAC2 cells.
Mouse p75 immunofluorescent surface staining and flow cytometry analysis of
zebrafish PAC2 cells transfected respectively with A) Mock vector, C) mouse
p75-YFP + α-phOx-KDEL ER intrabody, D) mouse p75-YFP + α-p75-KDEL ER
intrabody. As negative control of the immunostaining, mouse p75-YFP
transfected cells have been stained with fluorescently coupled secondary
antibody only (B). y-axis: antibody staining (APC-channel), x-axis YFP signal
from mouse p75-YFP fusion antigen.
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3.2.2. ScFv-hFc antibodies bind endogenous Cadherin 2 in PAC2
cells
The embryonic fibroblast zebrafish cell line PAC2 was analyzed for its
usefulness for the characterization of the ER intrabodies binding to
zCdh2. First, potential zCdh2 expression on the PAC2 cell surface had
to be verified. To obtain further information on the binding profile of the
scFv-hFc antibodies to zCdh2, not only the ones found to be specific in
FACS of primary cells and whole mounts before, but all the available
antibodies where tested in flow cytometry for binding to PAC2 cells. At
least 5,000 cells were included in the histograms shown in figure 16. All
antibodies shown before to be specific to zCdh2 (Sh1352-B11, -D7, -F4,
and -G9) by flow cytometry on primary cells positively stained PAC2
cells. SH1352-C6 and -F6 also bound to the surface exposed antigen
target, despite showing a distinct binding profile. SH1352-F6 shows, on
PAC2 cells, a binding profile analogue to the one of the antibodies
specific on primary cells. The antibodies SH1352-A3, -E1, -E11, -F9 and
-G12 were confirmed to bind not at all or only weakly, similar to what has
previously been seen with primary zebrafish cells (Figure 5).
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Fig. 16: Evaluation of scFv-hFc Abs binding to zCdh2 on PAC2 cells.
Immunofluorescent staining and flow cytometry analysis of zCdh2 on the surface
of zebrafish PAC2 cells with α-zCdh2 scFv-hFc antibodies. scFv-hFc mAbs were
used at 10 µg/mL.
3.2.3. Development of an intrabody knockdown/reporter vector for
zebrafish
To generate ER intrabody vectors, first all of the cDNA encoding the
scFvs against zCdh2 were extended by adding DNA encoding an
N-terminal signal peptide (SP) and two C-terminal detection tags
(HA-tag, Myc-tag) plus a KDEL retention peptide. These ER intrabody
expression cassettes (SP-scFv-HA tag-Myc tag-KDEL) were inserted
onto the right arm of the ER intrabody bidirectional knockdown vector
(Figure 17 A). On the left arm the fluorescent reporter gene tagRFP-T
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was inserted for the direct detection of the expression in living cells and
in vivo. Extensive studies were performed to select the right
enhancer-promoter combination for the planned vector capable to drive
bidirectional ubiquitous expression in mammalian cells as well as in vivo
in zebrafish. Combinations of different core enhancer sequences (SV40,
mouse CMV, human CMV, xenopus EF1-α), in fusion with the super
core promoter 2 (SCP2) (Juven-Gershon et al., 2006), were used to
express simultaneously two fluorescent reporter genes: mClover and
tagRFP-T. TagRFP-T has been cloned into the left arm of the construct,
while mClover into the right arm, always preceded by a zebrafish
optimized Kozak sequence (Grzegorski et al., 2014). To avoid the
methylation based silencing effects that accumulate over several
generations of transgenic zebrafish, we used CpG-free enhancer and
promoter sequences. Every expression cassette was cloned into a
minimal Tol2 transposon vector (Kawakami, 2007). The minimal Tol2
sequences allowed for the transposase mediated stable integration into
the zebrafish genome of our reporter cassette. Carriers expressing
mClover and tagRFP-T in different tissues were raised to adulthood (P0
generation). P0 offspring showing the most widespread transgene
expression was also raised to the adulthood (F1 generation). The
different expression systems have been studied in HEK cells after
transient transfection and in vivo in zebrafish embryos after injection of
the plasmid into one cell stage embryos (data not shown). Highest
expression levels of the two fluorescent reporters, bidirectionality
equilibrium, and reporter expression profile in vivo, have been selected
as criteria to determine the quality of each construct. The vector
GiR085-1, carrying the expression cassette
tagRFP-T-SCP2-xEF1α-mCMV- spacer-mCMV-xEF1α-SCP2-mClover
(Figure 17 B), drove the highest bidirectional expression levels and
showed the best transfection rates in HEK293 cells (Figure 17 C), or
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zebrafish primary cells (Figure 17 D-E). This vector also stood out by
allowing for a high diversity of tissues to express the two reporters in the
transient expression zebrafish model (Figure 17 F), an indication of
expression ubiquity.
The expression cassette from the bidirectional vector GiR085-1 was
therefore selected to generate the ER intrabody bidirectional knockdown
vector (Figure 17 A).
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Fig. 17: GiR085-1 reporter expression system and ER intrabody expression
cassette.
A) Schematic view of the ER intrabody bidirectional expression cassette. B)
Schematic view of the bidirectional fluorescent reporter expression cassette of
the vector GiR085-1.
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B) The gene expression driven by the construct has been assessed after
transfection in HEK293 cells (C), zebrafish primary cells (D-E), and in vivo
zebrafish after injection (F). D-E) Confocal imaging acquisition by Sassen W.A.
Scale bars: 150 µm. IR, inverted repeats; pA, poly-A tail; SCP2, Super Core
Promoter 2; xEF1a, Xenopus laevis Elongation factor 1-alpha enhancer;
mCMVenh., murine Cytomegalovirus enhancer.
3.2.4. Knockdown of zebrafish Cdh2 in PAC2 cells
To confirm whether expression of ER intrabodies against zCdh2 can
result in the depletion of endogenous antigen from the surface of fish
cells, PAC2 cells where transfected with expression vectors encoding for
different ER intrabodies anti-zCdh2. The zCdh2 surface levels where
analyzed in flow cytometry after 72 h. The unrelated α-phOx ER
intrabody was used as negative control. The amount of zCdh2 on the
surface of PAC2 cells transfected with α-phOx ER intrabody vectors was
set as 100 %. A reduction of zCdh2 surface levels induced by any of the
tested ER intrabodies against this antigen was interpreted as
knockdown. SH1352-C6, -D7, -F9, -G9, and, -G12 ER intrabodies
induced a reduction of the surface levels of zCdh2 (Figure 18).
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Fig. 18: zCdh2 surface levels quantification after ER intrabody expression
in PAC2.
PAC2 cells were electroporated with ER intrabody plasmid DNA. After 72 h from
the transfection, immunofluorescent staining and flow cytometry analysis was
used to quantify amount of zCdh2 on the cell surface. A) The histograms
represent the model used to classify an ER intrabody as positive or negative.
SH1352-A3 cells show comparable amounts of cells expressing zCdh2 to the
negative CTR- sample (α-phOx-KDEL), and is therefore negative. On the
contrary, SH1352-G12 sample show a reduced number of zCdh2
surface-positive cells. B) zCdh2 levels normalized to CTR-. One-way ANOVA, p
< 0.05, p < 0.01, p < 0.001.
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3.2.5. Zebrafish Cdh2 knockdown in HEK293 cells
To confirm whether ER intrabodies mediated retention of zCdh2 in the
ER was resulting in target accumulation inside of the ER lumen, HEK293
cells were co-transfected with both vectors expressing a zCdh2-mClover
fusion antigen and ER intrabodies against zCdh2 . This antigen contains
the whole zCdh2 extracellular and transmembrane domains, but lacks
the cytosolic domain (pCSE2.6-zCdh2-truncated aa 147-738). The
cytosolic domain has been replaced by the mClover fluorescent reporter
allowing one to measure the absolute cellular levels of zCdh2
(pCSE2.6-zCdh2-ECD-TM-mClover). The mClover emission was
acquired at 24 h after the co-transfection with an ER intrabody
expressing vector by flow cytometry. Of the five ER intrabodies, which
successfully mediated zCdh2 knockdown in PAC2 cells, all except
SH1352-F9 determined a reduction of zCdh2-mClover intracellular
levels (Figure 19). This reduction is intended as reduction of
mClover-positive cells, and/or reduction of the mClover protein levels
per cell, which is indicated by the median fluorescent intensity (MFI).
The representative histograms of figure 19 A show the transfection
efficiency, measured as mClover expression levels, was of
approximately 100 % in HEK293. The number of
zCdh2-mClover-positive cells per each sample have been normalized to
those of cells co-transfected with α-phOx-KDEL negative control
expression vector and zCdh2-mClover expression vector.
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Fig. 19: zCdh2-mClover amount quantification in ER intrabody+ HEK293.
HEK293 cells were co-transfected with ER intrabody and zCdh2-mClover
plasmid DNA. After 24 h from the transfection, immunofluorescent staining and
flow cytometry analysis was used to quantify the absolute intracellular amount of
zCdh2-mClover in transfected cells. A) The histograms represent the measure of
zCdh2-mClover levels in the presence of the unrelated ER intrabody
(α-phOx-KDEL), a negative ER intrabody specific to zCdh2 (SH1352-A3), or a
positive ER intrabody to zCdh2 (SH1352-G12). B) zCdh2-mClover levels
normalized on those from the α-phOx-KDEL negative control sample. MFI:
median fluorescence intensity. One-way ANOVA, p < 0.05, p < 0.01, p < 0.001.
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3.3. Transient ER intrabody mediated knockdown of zCdh2
impaired THN migration in vivo
After the functionality of the ER intrabody knockdown concept had been
established in zebrafish cells, the main remaining question was whether
ER intrabodies mediated knockdown of zCdh2 would have work in vivo
in zebrafish. For proof of principle, intrabody mediated knockdown of
Zebrafish Cadherin 2 in vivo was analyzed by its capability to interfere
with the natural migration of tegmental hindbrain nuclei neurons (THN)
and post-migratory primordia formation (Figure 20 A-C). THNs originate
from the upper rhombic lip (URL), from atoh1a+ neuronal progenitors.
From the same progenitors, but later, originate granule cells (GCs). In
Cdh2 mutants, GCs assigned to the formation of the the dorsomedial
corpus cerebelli accumulate in an ectopically located and enlarged
cluster, which remains in close proximity to the URL. We wanted to
verify ER intrabody mediated knockdown of Cdh2 in THNs could result
in a phenocopy of the migration phenotype observed in GC cells of
Cadherin2 mutant. To assess this, the genes of ER intrabody
SH1352-D7-KDEL, or the negative control α-phOx-KDEL, were cloned
into a vector mediating their expression, in combination to the
fluorescent reporter mKate, under the control of a UAS regulatory
element. Injection of these constructs into transgenic atoh1a:KalTA
embryos (Distel et al., 2010) should provide expression in atoh1a+
progenitors, and ultimately in THNs, of the ER intrabodies and the
mKate reporter protein. Consequently, the ER intrabody cassettes were
cloned into the right arm of a pTol1-5xUAS vector, while mKate
fluorescent reporter was cloned into the left arm. The ER intrabody
cassette was composed as previously described (Figure 17 A). To mark
all the atoh1a+ cells, an atoh1a:KaltTA4 fish line (Distel et al., 2010) was
crossed to Tg(4xUAS:GFP) carriers and resultant embryos at 1 cell
stage were injected with the vector pTol1-5xUAS ER intrabody/mKate.
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In SH1352-D7-KDEL ER intrabody/mKate plasmid injected embryos
was observed a time dependent increase in the size of the THN
neuronal clusters. At 32 hpf and 54 hpf, the area of the THN neuronal
cluster pair and their reciprocal distance was measured in mKate and
GFP double positive larvae (Figure 20 G). For quantification, the larvae
were imaged from a dorsal view in 5 µm z-stacks through the whole
developing cerebellum, while the quantification was conducted on
maximum z-stacks projections (Figure 20 H-I). The THN cluster area at
32 hpf did not differ substantially in size between larvae injected with
α-phOx-KDEL control (3153 ± 1008 µm²) or SH1352-D7-KDEL ER
intrabody (3515 µm² ± 1450 µm²). However, at 54 hpf the cluster area of
SH1352-D7-KDEL larvae (3374 µm² ± 848 µm² (N = 13 embryos)) was
found to be 33.78 % wider than in α-phOx-KDEL larvae
(2522 µm² ± 787 µm² (N = 16 embryos)). Consistent with this result, the
distance between the THN clusters was found to be comparable at 32
dpf (11.8 µm ± 9 µm in α-phOx-KDEL larvae and 13.4 µm ± 8.4 µm in
SH1352-D7-KDEL larvae), but reduced at 54 hpf in SH1352-D7-KDEL
larvae (34.9 µm ± 11.7 µm) compared to the control
(53.4 µm ± 13.2 µm). The phenotype created by the expression of ER
intrabodies against zCdh2 in THN shows strong analogies to the GCs
migration phenotype previously described in Cdh2 mutant zebrafish
(Rieger et al., 2009).
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Fig. 20: In vivo ER intrabody mediated knockdown of zCdh2 in THNs.
A) Schematic lateral view of developing zebrafish brain. B-C) THN migration
schematic representation in lateral view. THN migrate rostrally (blue arrows)
from the URL towards the midbrain-hindbrain boundary (MHB), and tangentially
(green arrows) along it. D) Schematic dorsal view of developing zebrafish brain.
E-G) Confocal images recorded at 54 hpf from atoh1a:KalTA/4xUAS-GFP fish
injected with pTol1-5xUAS ER intrabody/mKate vector. Images show the
maximal projection of multiple 5 µm z-stacks acquired. The interrupted line
delimits the area of the THN primordial nuclei. Scale bar: 50 µm. Raw images
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courtesy of Daniela Münch. H-I) THN primordia area and their reciprocal
distance quantification at 32 hpf and 54 hpf. Both parameters did not significantly
vary between SH1352-D7-KDEL and α-phOx-KDEL samples at 32 hpf. On the
contrary, at 54 hpf a significant increase of the THN primordia area, and
consequent reduction of the distance between the two, were registered in
SH1352-D7-KDEL samples compared to the control. Data courtesy of Daniela
Münch. One-way ANOVA, p < 0.05, p < 0.01, p < 0.001.
3.4. Generation of an inducible bidirectional expression vector
During the process of generation and validation of an expression system
capable of driving widespread transgene expression in vivo in zebrafish
(see paragraphs: 2.2.1.11 and 3.2.3), we observed some of the tested
enhancer/promoter combinations were inducible upon injury (Figure 21).
All the tested enhancer/promoters were tested in a bidirectional
orientation. TagRFP-T or mClover fluorescent proteins were cloned
respectively into the left or the right arm of the construct and used to
detect gene expression upregulation upon injury. Increased levels of
fluorescent reporter expression after injury could only be found in
transgenic larvae carrying the CpG-free mouse CMV enhancer core
element : GiR085-1
(tagRFP-T-SCP2-xEF1a-mCMV-spacer-mCMV-xEF1a-SCP2-mClover)
or GiR077 (tagRFP-T-SCP2-mCMV-spacer-mCMV-SCP2-mClover).
The expression cassette of these constructs are shown respectively in
Figure 17 A and 21 A. In figure 21 is shown the fluorescent reporter
expression induction in 4 dpf GiR077 larvae at 24 h after spinal cord
injury. The induction is circumscribed to the injury site. An analogue
construct to those described, is characterized by the presence in tandem
of the human CMV enhancer and the xEF1a enhancer to the SCP2.
Larvae carrying this construct do not show any fluorescent reporter
upregulation upon injury (data not shown).
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This finding excludes the xEF1a enhancer or the super core promoter 2
could contribute to confer constructs GiR077 and GiR085-1 the
characteristic induction upon injury. Between the two, GiR077 carriers
were characterized by very low basal transgene expression in uninjured
animals. At 24 hpf, GiR077 F1 transgenic larvae weakly expressed the
transgenes in the eye and in the nasal vesicle (Figure 22 B and C), while
from day 2 pf expression remained in the lens and the lateral line (Figure
22 D). From day 5, a punctate expression in the intestine appeared
additionally (Figure 22 E). With the exception of the lens, the observed
expression pattern was previously described as NF-κB specific (Kuri et
al., 2017).
Primary cells derived from 3 dpf F1 GiR077 transgenic zebrafish larvae
allowed for testing the enhancer response upon stimulation with TNFα, a
known activator of the NF-κB pathway. The day after fish dissociation,
cells were cultured 8 h in starvation medium (1 % FCS instead of 10 %
FCS) and then treated with 30 ng/mL TNFα or left untreated. After 12 h,
the mClover-positive cells and relative median fluorescent intensity (MFI)
were measured in flow cytometry. TNFα stimulation resulted in a
17.24 % increase of the number of mClover-positive cells.
The overall number of cells which could be activated could be
dependent on the expression of either one of the TNF receptors: TNFR1
(TNF receptor type 1) and TNFR2. Hence, more significant is the
comparison of the mClover expression levels within positive cells of the
TNFα treated over untreated sample, which is indicated by the median
fluorescent intensity of the mClover-positive cells (MFIpos.) and not of the
overall sample (MFItot.). This value was more than 6 times higher in the
treated sample, giving a precise indication of the expression
upregulation 12 h after TNFα treatment in cells sensitive to this cytokine.
Results
110
Fig. 21: Spinal cord injury induced expression upregulation in GiR077
transgenic animals.
Image acquisition 24 h after spinal cord injury of 5 dpf brass larvae (A) or GiR077
larvae (B), expressing the tagRFP-T and mClover fluorescent reporters under
the control of mCMVenhancer- SCP2promoter elements. Strong reporter
expression is observed at the injury site.
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Fig. 22: Mouse CMV enhancer driven reporter expression in vivo.
A) Schematic representation of the CpG-free bidirectional expression cassette
flanked by the reporter genes tagRP-T and mClover. Canonical and
non-canonical NF-κB sites present in the mouse CMV enhancer sequence are
highlighted. Fluorescent mClover signal has been recorded in GiR077 F1
transgenic zebrafish embryos respectively at B-C) 1 dpf, D) 3 dpf, and E) 5 dpf.
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At every developmental stage documented mClover expression resembled the
typical NF-κB expression profile described in literature for zebrafish, except the
additional reporter gene expression in the lens. Dpf, days post fertilization; IR,
inverted repeats; pA, poly-A tail; SCP2, Super Core Promoter 2; mCMVenh.,
murine Cytomegalovirus enhancer.
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Fig. 23: TNFα induced transgene expression upregulation in GiR077
primary cells.
Primary zebrafish cells obtained from 3 dpf GiR077 transgenic larvae where
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cultured in low FCS medium (1 % FCS) for 8 h prior treatment with 30 ng/mL
TNFα. Images of control sample and TNFα treated cells A-B) Bright field and
C-D) mClover fluorescence acquisition. E-F) Flow cytometry analysis offers the
comparison of the mClover-positive cells percentage and mClover expression
upregulation within positive cells (MFIpos) for untreated vs TNFα-treated cells.
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4. Discussion
4.1. Generation of novel monoclonal antibodies against zCdh2
4.1.1. recAbs improve the detection of Cdh2 during zebrafish
development
In this project we generated 11 novel sequence-defined human scFv
antibodies against zebrafish Cdh2 via phage display. Four of these
antibodies were found to be cross-reactive with the human Cdh2 in
ELISA (Figure 4), three of which also bound to Cdh2-positive human cell
lines (Figure 11). Before evaluating the efficacy of these scFv’s as
ER intrabodies, they all underwent a thorough binding profile
characterization, with focus on specificity towards the target. Within this
process, we have demonstrated that several zebrafish structures
identified as Cdh2-positive in at least six different published studies
(Tuttle et al., 2014; Xing et al., 2015; Han et al., 2016; Mochizuki et al.,
2017; Gays et al., 2017; Powell et al., 2018), which relied on staining
with commercially available polyclonal antibodies, may show potentially
false positive. These misleading results should be re-evaluated
accordingly. Our sequence defined monoclonal antibodies here may
serve as better alternatives for Cdh2 detection in whole mounts, FACS,
and other assays. Finally, we validated two inexpensive, but extremely
reliable approaches for specificity characterization of antibodies against
zebrafish endogenously expressed membrane targets or whole protein
repertoire after fixation, which are based on the use of antigen null
mutants and fluorescent reporter antigen-fusion fish lines.
Zebrafish Cdh2 is member of a large type I transmembrane protein
family of adhesion molecules characterized by high structural similarity.
The zCdh2 extracellular domain is composed of 5 consecutive Ig-like
domains responsible for the formation of cell-cell contacts. Based on
InterPro domain classification (ID: IPR007110) (Finn et al., 2017), this
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very common protein architecture (Smith and Xue, 1997; Teichmann
and Chothia, 2000; Barclay, 2003) can be found in 2503 different
zebrafish proteins (ca. 10 % of the zebrafish proteome accordingly to the
zebrafish genome project (Howe et al., 2013). The CATH Protein
Structure Classification database sequence/structure diversity
comparison shows the low degree of sequence/structure diversity
among the cadherins compared to other protein families (CATH
Superfamily 2.60.40.60). For example, zCdh2 amino acid identity shared
with zCdh4-ECD is 68 % for ECD1. This high degree of similarity
requires, more than for other targets, a careful process of antibody
binding specificity assessment.
We established primary cell flow cytometry to analyze this in detail,
allowing to directly compare Wt, zCdh2 null mutants (pac mutant), and
zCdh2-GFP-RFP (zf516 Tg) derived cells. In the latter, the commercial
polyclonal antibody GTX125885 stained about 65 % of the cells derived
from zf516 Tg larvae, while only 29 % of those cells were actually Cdh2
positive, as determined measuring, in parallel to the surface antibody
staining, also the GFP fluoresce from Cdh2-GFP-positive samples
(Figure 6). More than half of the cells stained by the current "gold
standard" antibody did not express Cdh2 at all. This huge false positive
signal was corroborated by the observation that approximately 45 % of
the pac mutant cells were positive - in a fish line where antigen
expression is absent (Lele et al., 2002).
In whole mount IHC on 3 days old zf516 Tg larvae (Figures 7 and 8),
GTX125885 partially recapitulated the zCdh2-GFP expression profile,
but additionally stained several zCdh2-GFP-negative tissues. Indeed,
along the whole fish body, and markedly in the eyes, of homozygous pac
mutant larvae, a substantial antibody staining could be observed. Most
strikingly, despite its high off-targeting binding, GTX125885 only weakly
stained the spinal cord, a tissue where Cdh2-GFP is highly expressed
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(Figure 7). Recombinant human MAbs SH1352-G9 and −B11
specifically recognized zCdh2 in flow cytometry on the surface of living
primary cells (Figure 5-6), as well as recapitulated precisely the
zCdh2-GFP expression pattern profile in whole mount IHC (Figure 7-9).
Intriguingly, SH1352-D7 mAb was found to be more suitable in flow
cytometry than in whole mount immunostaining and vice versa for
SH1352−F4 mAbs. This aspect spotlights the absolute necessity of
defining antibody specificity profiles in different assays separately, and
add a further element to the notion antibody specificity is not an absolute
and immutable property, rather an aspect to contextualize in respect of
sample size and preparation, antibody format, and concentration (Uhlen
et al., 2016). In this respect, the use of whole mount IHC or whole larvae
derived primary cells can be considered preferable to the same tests
conducted on a single tissue slice or a single cell line. The highly specific
monoclonal antibodies that we generated for flow cytometry may in the
future also allow for sorting zCdh2-positive cells for further multiple
analysis, e.g. of their transcriptome (Namikawa et al., under minor
revision) or proteome, but also for the generation of type-specific cell
lines. A small percentage of GFP-positive cells from zf516 Tg larvae
could not be stained by either polyclonal antibody GTX125885 or our
highly specific scFv-hFc antibodies SH1352-B11, -D7, -F4 and -G9 in
flow cytometry, or IHC assays. This finding should not surprise as
emission in the GFP channel is attributed to the expression of
Cdh2-GFP-RFP, but also to eCFP expression in the lens of zf516 Tg fish,
as shown in the whole mount imaging (Figure 7-8). These cells are
zCdh2-negative and can not be stained therefore by the antibody.
During the generation of the zf516 Tg transgenic line, crybb1:ECFP was
introduced into the genome to allow for the screening of transgenic
progeny earlier than Cdh2 expression occurs in the developing embryos
(Revenu et al., 2014; Jiang et al., 1996).
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Despite the almost negligible emission of the eCFP in the GFP channel
when excited by a 488 nm laser, crybb1 (crystallin Beta B1), as other
crystallins in the lens, is present at extremely high concentration, overall
estimated to 300–900 mg/mL (Han and Schey, 2006; Zhao et al., 2011).
Hence eCFP expression should be similarly high when driven by the
crybb1 promoter. Of all the fluorescent proteins with emission maximum
in cyan color, ECFP is also known to have a bimodal excitation and
emission spectrum, which enhances this phenomenon (Greb 2012;
Technical notes by Zeiss). Another explanation may be found in the
incubation time (24 h) of the cells after dissociation (which cleaves the
Cdh2 on the cell surface). Incubation time is required to allow for the
reconstitution of the antigen on the cell membrane. In some cells more
than 24 h may be required to display Cdh2-GFP-RFP on the cell surface,
while in the same cell some protein may already be folded in the
endoplasmic reticulum and therefore already be fluorescent.
4.1.2. Epitope analysis
The novel antibodies generated by phage display provided significantly
diverse reactivity patterns, suggesting that they bind different epitope
structures. Of the five scFv-Fc mAbs (SH1352-B11, -C6, -D7, -F4, and
-G9) tested for binding in the Spot membrane assay (Vernet et al., 2015),
only two mAbs (-B11 and −C6) could be mapped on synthetic peptide
(Figure 12). In Western blot all these mAbs bound the zCdh2-ECD-mFc
antigen prepared under reducing conditions (Figure 14). On the other
hand, SH1352-B11 and -C6 were the only antibodies, of the tested 5,
capable of binding zCdh2-ECD1 fragments in ELISA (Table 3.5). This
suggests that SH1352-D7, -F4, and -G9 mAbs may recognize partially
conformational epitopes, which are disrupted by domain breakdown, but
may be preserved in western blot analysis as a result of partial refolding
or incomplete SDS denaturation. It underlines again the need to always
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link statements on antigen specificity to the respective particular assays.
The epitope region of those antibodies which did not react on
zCdh2-ECD1 PepSpot membrane may be identified using alternative
approaches which do not intrinsically prevent protein folding (Fühner et
al., in press).
The two epitopes amenable to Spot analysis mapped to a structural
homology model of zCdh2-ECD. This model was generated starting
from the available crystal structure of the mouse Cdh2 (3Q2W), based
on the high sequence similarity of its ECD to the one of zebrafish Cdh2
(75.4 % amino acid similarity for the whole ECD; 80.4 % within ECD1).
Sequence similarity of the epitope (VDINGNQMENP, Uniprot Q90275
aa 227-237) of mAb SH1352-B11, which is cross-reactive to human
Cdh2, was tested by in silico analysis using the non-redundant protein
sequence databases/Protein blast. Hits having E-value < 1 were: human
Cdh2 (VDINGNQVENP) and zebrafish Cdh4 (VDINGNQMEPP). We
found that SH1352-B11 recognizes the human Cdh2, but not the zCdh4.
Hence, we can speculate that the amino acidic substitution N236P
disrupts the antibody-antigen interaction, while M234V does not - may
be since the proline changes the peptide backbone angle while M>V
only changes a side chain. Interestingly, the residues V227, I229, N230,
and Q233 included in the epitope of SH1352-B11 are also described to
be involved in the formation of the cis interface of association between
two Cdh2 monomers, necessary for the lateral cadherins association on
the cell surface (Harrison et al., 2011). In this process, the Cdh2-ECD1
of a monomer interacts with the Cdh2-ECD2 of a second monomer. This
type of interaction is highly specific and, beside Cdh2-Cdh2 homophilic
interaction, it can only mediate Cdh2-Cdh4 heterophilic interaction, but
not Cdh2-Cdh1 one (Shan et al., 2000; Vendome et al., 2014). This
aspect further contributes to delineate the peculiarity of this epitope. As
the disruption of the cis interface in mouse Cdh2 mutant cells
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(V227D/V320D) compromises the formation of adherens junctions
(Bunse et al., 2013), SH1352-B11 binding may exert a similar effect, an
effect which may be evaluated in the future. Nevertheless, these findings
promise that SH1352-B11 may encode for Cdh2-function interfering
antibody. Sequence similarity studies for the SH1352-C6 epitope region
(Uniprot: Q90275: aa159-169; SRKQFPEELVK) showed the existence
of several zebrafish proteins sharing high (E-value < 1) sequence
similarity to it. This result may explain the tendency of this antibody
towards some unspecific binding.
On the contrary, the same region of the human Cadherin2 was found to
be highly dissimilar (E-value = 50), in accordance with the experimental
evidence that SH1352-C6 did not bind hCdh2-ECD-mF in ELISA.
Using ELISA on individual zCdh2-ECD domains it was found that ten of
the eleven antibodies generated against recombinant zCdh2 recognize
the first ECD of the protein. Potentially, they may all interfere with the
“strand-swap” formation of trans interaction between two opposing
cadherins molecules (Bunse et al., 2013), encouraging to study a
possible application of the new mAbs for functional studies in the future.
4.1.3. Future antibody specificity standards and specificity
assessment
At present, the availability of antibodies specific against zebrafish
proteins is limited despite the established value of the zebrafish model
organism for multiple research purposes. Two of the main strengths of
this model are its external fertilization and development, as well as its
transparency, which together allow for in vivo imaging at cellular
resolution of the intact developing embryo. Developmental studies often
include protein expression pattern analysis, primary cell sorting, and
transcriptome analysis studies (Namikawa, et al., under minor revision).
These techniques rely on highly specific antibodies suitable for different
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experimental setups. While generation of phage-display derived
sequence defined monoclonal antibodies today is robust, fast, and
affordable (Schofield et al., 2007; Mersmann et al., 2010; Colwill et al.,
2011) the process of validation is the most time-consuming step for
research for antibodies from all sources, and not only requires
knowledge of the antibody generation process, but also, and most
importantly, of the antigen to be detected. This aspect, together with the
reduced market for research antibodies to zebrafish proteins,
contributes to explain the restricted availability of antibodies against
non-mammalian targets. Most of the available antibodies against
zebrafish proteins are antibodies generated against mammalian
antigens that cross-react with their zebrafish homologous proteins. This
concept is well explained by the founder of CiteAb DrChalmers in an
interview on the topic (Helsby 2017). Accordingly to CiteAb, a
devastating 94.2 % of the mammalian - zebrafish cross-reactive
antibodies are polyclonal (4,698 of 4,77 primary antibodies), with their
intrinsic risk of exhibiting unwanted reactivities, an issue which involves
many antibodies in use (Taussig et al., 2018; Goodman 2018; Bradbury
and Plückthun 2015; Berglund et al., 2008; Dove, 2017). A systematic
comparison of over 5.000 polyclonal and monoclonal research
antibodies from 51 different origins showed that not even 50 % of these
antibodies recognized the assigned antigen at all (Berglund et al., 2008).
Further, the difficulty to identify identical batches or clones of
commercial antibodies - and if successful, to obtain an identical aliquot,
negatively affects our capability to reproduce antibody based studies.
This not only prevents reproduction of useful studies but in many cases
makes it impossible to retrospectively analyze whether a discovery
based on antibody staining was the result of specific or unspecific signal
- a problem which cannot be underestimated (Berglund et al., 2008). In
this framework, the use of monoclonal hybridoma antibodies over
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polyclonal preparations can not be considered as the most effective
solution for multiple reasons.
First, almost half of published mAb-producing hybridoma cell lines
generated so far for research purposes can be assumed to be lost today,
partly due to the expense of storage in liquid nitrogen (Alan Sawyer,
personal communication). Second, hybridoma derived antibodies can
not be further considered unequivocally monoclonal. In an extensive
effort, Bradbury and collaborators (Bradbury et al., 2018) sequenced
187 monoclonal hybridomas from a worldwide consortium of different
laboratories proving that over than 50 % of these hybridoma cell lines
expressed RNA chains encoding for more than one antibody. One third
was even shown to secrete more than one IgG, resulting in the
production of an oligospecific mixture of antibodies, thus impairing
specificity and affinity. The only antibodies which automatically can be
considered as monoclonal are sequence defined mAbs generated with
recombinant technologies, like phage display. These antibodies can be
documented by their sequence, providing infinite reproducibility of
studies where they had been used even if the original clone was lost,
since it can always be reconstituted from the electronically stored or
printed amino acid sequence. While polyclonal antibodies and mAbs
from hybridoma supernatants should not be systematically categorized
as unspecific, we must be aware that they certainly require more care
than sequence defined reagents when assessing their specificity.
Unfortunately, if the risk of unwanted cross-reactivities is well known,
this is not adequately kept in consideration when testing and validating
the available research products (Goodman 2018). Here, the zebrafish
model offers ample solution to do so, as a broad collection of knockout
lines generated with ZFN, TALEN or CRISPR/Cas9 mutagenesis, and
many mutants derived from genetic screens, are available for accurate
comparisons with the wild type animals.
Discussion
123
In this work, we demonstrated that the advantages of the zebrafish
model could be integrated into a pipeline for antibody specificity
assessment that is relatively low-cost. It can be assumed that scale up
would be possible thanks to readily available automated devices like
HTP automated flow cytometry analyzers and automated fish sorters
and imagers (Guo et al., 2017). As the portfolio of antibodies to zebrafish
proteins has yet to be expanded, it would be highly beneficial to adopt
similar exhaustive specificity assessment in the future to improve the
quality of future antibody-based studies. Consequently, we hope this
work helps to raise the awareness of many scientists who unwittingly
ignore the current limits of antibodies based studies reproducibility and
reliability. Also, it has to be hoped that antibody providers will reexamine
their current standards for specificity assessment and update their
antibody generation pipelines to more appropriate current recombinant
technologies. In alternative, the zebrafish community in collaboration
with a laboratory specialized in the in vitro generation of antibodies,
could promote an initiative for the generation and characterization of
antibodies against the most relevant antigenic targets in the field.
Antibody validation, accordingly to the high specificity standards
presented in this work, would take place in several independent
laboratories specialized in working with designated antigen targets. As
result of this community effort, antibody sequences could be made
publicly available on the The Zebrafish Information Network (ZFIN) for
the all community to use.
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4.2. ER Intrabody mediated knockdown in zebrafish
4.2.1. The zebrafish ER retention mechanism supports ER
intrabodies
In 1990 Hardwick, Semenza, and colleagues described (Semenza et al.,
1990; Hardwick et al., 1990) that the KDEL receptors ERD1 and ERD2
are necessary for the sorting of ER luminal proteins in yeast. Reduction
of ERD2 expression leads to the secretion of HDEL (analogue of KDEL
in yeast) tagged proteins, while upregulation of ERD2 expression
increases HDEL-proteins retention. At that time it was already known
that this mechanism is typical of mammalian cells as well (Munro et al,
1987), and that it involves the transit of the KDEL tagged proteins to the
cis-Golgi and from this compartment the retrieval to the ER lumen
(Pelham, 1988). This retention mechanism can be found even in plants,
and can be therefore considered a highly conserved feature of all
eukaryotic cells. Intriguingly, the KDEL retention has been shown also in
unicellular organisms missing golgi-like organelles as Giardia lamblia
(Zamponi et al., 2017).
Not too surprisingly, zebrafish is no exception. Three genes encoding
KDEL receptors are found in the zebrafish genome kdelr2a, kdelr2b, and
kdelr3 (Thisse et al., 2001), where both kdelr2 genes are homologous of
mammal ERD2. Studies on the three human KDEL receptors proved
their different specificity towards different variants of the KDEL retention
signal. Based on the Prosite motif for ER localization
[KRHQSA]-[DENQ]-E-L and newly discovered ER localization peptides
(Raykhel et al., 2007), exist at least 59 different peptides which mediate
good ER protein retention. The most effective KDEL mediated retention
will depend on the absolute, as well as relative, expression level of the
three KDEL receptors, and their respective specificity.
Despite the KDEL based retention mechanism is proven to exist in
zebrafish, the ER intrabody knockdown was so far only proven to work in
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human, mouse, rat and plant cells, and had yet to be confirmed to work
in the zebrafish model. The ER intrabody against mouse and rat p75
SH325-G7 (Zhang et al., 2012) was chosen for this validation in
zebrafish PAC2 cells. The use of an ER intrabody binding to a mouse
protein required the co-expression of the antigen target fused to a
florescent reporter together with SH325-G7-KDEL or of the negative
control ER intrabody α-phOx-KDEL. Contrarily to the negative control
sample (Figure 15 C), the presence of mp75-YFP positive cells which
did not express the antigen on the cell surface (APC-negative) in the
SH325-G7-KDEL sample (Figure 15 D), clearly proved the efficacy of
this ER intrabody in mediating mp75 knockdown.
This experiment did not only proved for the first time that ER intrabody
mediated knockdown works in zebrafish cells, but that it also can work in
a co-transfection heterologous model with high expression levels of the
targeted protein.
4.2.2. Endogenous zCdh2 knockdown by ER intrabodies
The new ER intrabodies SH1352-C6, -D7, F9, and -G9 induced a
reduction in the number of zCdh2 positive cells by about 20 %, while
-G12 up to ~50 % in cell culture (Figure 18). The other mAbs did not
exert any effect. The effective ER intrabody mediated reduction of
antigen levels from the cell surface was partially masked by two factors.
First, by the limited ER intrabody transfection efficiency, diluting the
signal because untransfected cells by definition can not show any
knockdown. Average transfection efficiency after electroporation in
PAC2 cells was at most ~50 %. Second, the low Cdh2 signals in FACS,
resulting from low endogenous expression levels, did not allow a
complete separation of the Cdh2+ and the Cdh2- cell populations.
Interestingly, the apparent affinity of the antibodies (as ranked from
titration ELISA results in figure 4) does not correlate with knockdown
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efficiency, an observation which has also been previously reported for
another antigen (Zhang et al., 2012). Similar to the observations for p75,
SH1352-G12 was the antibody with the lowest affinity to the antigen in
ELISA, but the most efficient in mediating Cdh2 retention. Epitope
accessibility in the ER compartment on a freshly forming protein may be
significantly different from the conditions used to characterize the
antibodies using fully folded, matured, and purified proteins.
Alternatively, it cannot be ruled out that this difference may reflect each
ER intrabodies relative expression level and folding efficiency in fish
cells. These factors can account for knockdown levels more than
antibody affinity, and have to be considered in future studies.
4.2.3. The role of antigen degradation after ER retention
The assays which demonstrated the ER intrabody-mediated reduction of
zCdh2 from the cell surface provided indirect evidence for the efficacy of
the antigen retention in the ER, but did not elucidate whether the
retained antigen is degraded afterwards or accumulates in the ER
compartment.
In this study, we assessed this by comparing the absolute antigen levels
to the cell surface levels of the antigen using an mClover::zCdh2 fusion
protein, which allowed its detection independently from its intracellular
localization. Significantly, all of the ER intrabodies that mediated a
reduction of surface zCdh2 on PAC2 cells also provided a reduction of
the endogenous zCdh2 levels, indicating zCdh2-mClover protein
degradation in ER intrabody co-transfected HEK293 cells (Figure 19).
Cdh2-mClover degradation, indicated by disappearance from the ER
lumen, has also been described before for ER intrabodies against
VCAM-1 (Strebe et al., 2009). In our experiment the antigen was
overexpressed and its levels can be considered to have been
significantly higher than the endogenous levels found in PAC2 cells. In
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this context, ER intrabodies mediating antigen knockdown are more
likely to reduce the number of antigen molecules per cell (Median
fluorescent intensity, MFI, reduction), rather than the number of
antigen-positive cells. Indeed, when comparing the two measurements,
it can be noticed that every sample which showed a reduction in the
number of zCdh2-mClover-positive cells also showed an even higher
reduction in the MFI which indicates the number of zCdh2-mClover
molecules per cell. These results are also in line with other studies which
showed the absence of antigen accumulation and UPR activation in ER
intrabody expressing cells (Zhang et al., 2012).
The proof of retained antigen degradation is a key feature for the
successful use of the ER intrabody technology, since without it, damage
induced by accumulation of ER intrabody-bound protein into the ER
compartment may lead to false positive phenotypes. It seems to be
necessary, however, to confirm this aspect for every different antigen,
the naive degradation pathways of which may differ significantly.
4.3. ER intrabody knockdown in zebrafish in vivo
4.3.1. THN migration depends on Cdh2 activity
The atonal bHLH transcription factor 1a, more commonly Atoh1a, is a
zebrafish transcription factor with proneural activity (Ben-Arie et al.,
1997). Its temporal expression is not limited to the developing brain as
atoh1a expression persists in the adult cerebellum, labeling neuronal
progenitors. Neuronal progenitors expressing Atoh1a give rise to
multiple neuronal populations including cerebellar granule cells and
output neurons, as well as tegmental hindbrain nuclei neuron (THN)
(Volkmann et al., 2008 and 2010; Chaplin et al., 2010; Kani et al., 2010).
Between 24 hpf and 48 hpf, newly arisen THN migrate from the URL,
first rostrally towards the midbrain hindbrain boundary (MHB) and then
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ventrally along the MHB (Figure 20 A-C) (Köster and Fraser, 2001;
Machold and Fishell, 2005; Wang et al., 2005; Wilson and Wingate,
2006). These cells cross the cerebellar primordium and terminate in the
tegmental hindbrain where they form neuronal clusters (Volkmann et al.,
2010; Theisen et al., 2018). These clusters will develop into different
hindbrain nuclei, including the secondary gustatory/viscerosensory
nucleus, the nucleus isthmi, and the superior reticular nucleus. These
nuclei project to the optic tectum and the hypothalamus with a potential
influence on autonomous function, gustatory and visual system, as
described for their equivalent mammalian brain structures, the
parabrachial, parabigeminal, and laterodorsal-pedunculopontine
tegmental hindbrain nuclei (Volkmann et al., 2010; Wulliman et al.,
2011). First, THN and subsequently granule cells (GCs) originate from
the URL atoh1a+ neuronal progenitors. The integrity of migratory
processes of GCs has already been shown to depend strictly on Cdh2
activity in zebrafish (Rieger et al., 2009), as well as in mouse (Kerjan et
al., 2005), while less is known in regard of the role of Cdh2 in THN
migration and tegmental nuclei formation.
ER intrabodies against Cdh2 (SH1352-D7-KDEL) or the negative control
α-phOx-KDEL have been expressed in atoh1a+ THN (Figure 20 E-G)
and their effect on neuronal cluster formation studied at 32 hpf and 54
hpf (Figure 20 H-I). At the latest time point the cluster area of
SH1352-D7-KDEL larvae was in average 33.78 % wider than in control
larvae, while the distance between the clusters reduced by 34.64 %. On
the contrary, no significant difference was found at 32 hpf between the
two samples. This indication is in accordance with studies which
underline that ER intrabody knockdown efficacy is a process whit a strict
time dependency (Zhang et al., 2012; Marschall et al., 2014).
Also, ER intrabody plasmid was injected into zebrafish embryos, which
implies only several hours after the first ER intrabody molecules were
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produced and actively mediating the knockdown of zCdh2. Furthermore,
the protein expression after DNA injection is mosaic, so that not all the
atoh1a+ progenitors were actually ER intrabody positive. These aspects
consent to hypothesize the generation of stable zebrafish lines
expressing the ER intrabody in all the atoh1a+ cells starting from the first
moment after spawning may induce a more pronounced phenotype.
Another limiting factor having a direct impact on the process is the
antigen turnover and recycling time, which obviously can differ a lot
between different cell surface proteins.
In conclusion, the presence of a significant phenotype at 54 hpf, but not
yet at 32 hpf, may reflect the lag time necessary for intrabody production
plus the depletion of Cdh2 and the generation of a quantifiable effect on
overall cell behavior. It may be wise to generate stable ER intrabody
lines and allow for even longer times before phenotype assessment in
future studies.
Rieger and colleagues (Rieger et al., 2009) showed Cdh2 cell-cell
interaction is necessary to maintain the polarity of GCs and their
chain-like orientation during the migration of URL-derived GC
progenitors. Particularly the GCs which form the dorsomedial corpus
cerebelli in wild type animal, in Cdh2 mutants remain in close proximity
to the URL and accumulate in an enlarged ectopically located cluster.
The increased area of the THN tegmental nuclei primordia observed
upon ER intrabody mediated Cdh2 depletion and their reduced distance
from the origin of migration (URL) are in accordance with these previous
data on Cdh2 mutant granule cells. It remains to be unveiled if the
downregulation of Cdh2 affects migration in the two different cell types
by the same molecular mechanism.
The atoh1a+ THN progenitors (Distel et al., 2010), as well as progenitors
of GCs (Rieger et al., 2009; Kani et al., 2010; Volkmann et al., 2008),
migrate radially from the URL towards the MHB at first, then tangentially
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along the MHB later to finally terminate respectively in the tegmentum or
later in the cerebellum (CCe/Va). Cdh2 role during GCs migration
consists in coordinating cell-cell contacts and cell polarity via the
remodeling of adherens junctions (Rieger et al., 2009). Despite THN and
GCs originate from the URL and share part of the migratory route, Cdh2
role in migration may differ between the two cell types. Future studies
will be needed to characterize the molecular mechanisms of migrating
THN. The use of stronger promoters can increase ER intrabody levels
and thereby knockdown efficiency. Different ER localization motifs
should also be tested to assess which one has the best ER retaining
potential in zebrafish. At least 24 possible variants have been listed as
the Prosite motif [KRHQSA]-[DENQ]-E-L (Hulo et al., 2006). Recent
studies in human cells showed specificity and affinity level of different
KDEL-like variants towards the KDEL receptor 1, 2, or 3 can vary
profoundly (Raykhel et al., 2007).
While classic gene knockout approaches completely and irreversibly
deplete zCdh2 expression, our approach allows to limit the
downregulation of this adhesion molecule in a specific cell type. This
may become crucial for the understanding of brain development, as in
the Cdh2 mutant fish the whole brain tissue architecture becomes
compromised, limiting the capability to differentiate between direct and
indirect effects of the knockout on a specific cell type.
4.4. Ubiquitous enhancer/promoter generation and characterization
Currently, the best ubiquitous-like promoter available for zebrafish is the
ubiquitin promoter (Mosimann et al., 2011), which with its 3.5 Kb in
length it is not suitable for the use in bidirectional expression systems. In
this work we tested different core enhancers combinations in tandem
with the SCP2 screening for ubiquitous and bidirectional expression in
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vivo in zebrafish. The use of viral enhancers with or without the addition
of the Xenopus laevis-derived elongation factor 1a enhancer (xEF1a) did
not succeed, confirming the known difficulties in the field for the
generation of such type of expression system.
4.5. TNFα inducible enhancer/promoter generation and
characterization
Zebrafish is gaining popularity as a model for studying the etiology of
CNS associated human diseases. Neurodegenerative diseases are
often characterized by abnormal cell stimulation via NF-κB activatory
cytokines (Verma et al., 2004). Hence, NF-κB responsive genetic
elements constitute valuable tools to study the etiology of these
diseases.
The cytomegalovirus (CMV) major immediate-early enhancer/promoter
is known to respond to common Toll-Like-Receptors (TLRs) agonists
such as TNF-alpha (Ramanathan et al., 2006; Koskinen et al., 1999;
DeMeritt et al., 2004). In these viruses, gene expression depends strictly
on the host transcriptional machinery (Kozak and Roizman, 1974). The
use of enhancer/promoter sequences recognized by host transcription
factors which are induced during the infection, constitute an evolutionary
advantage for the virus (Kropp et al., 2014; Kropp et al., 2015). On the
other side, we can benefit from the use of these disease-activated
enhancers to drive transgene expression regulated in time and space.
During a screening campaign for the identification of virus-derived
enhancers capable of driving ubiquitous expression in vivo in zebrafish,
we found the mCMV CpG-free enhancer element can be induced upon
injury in vivo (Figure 21) or upon TNFα stimulation in cell culture (Figure
23). Two CpG-free mCMV elements fused to SCP2 elements were
cloned back to back to drive bidirectional expression. The expression
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profile of the transgenes under the control of this bidirectional
expression system in zebrafish (Figure 22 B) resembles the expression
profile typical of NF-κB (Kuri et al., 2017).
The reporter system we generated stands out for two aspects we found
meritorious of attention. First, the need of generating a
methylation-insensitive expression cassette, as the effect of DNA
methylation-dependent gene silencing is well described (Meissner 2010)
and particularly in respect of transgene expression in zebrafish (Pang et
al., 2015). Second, the need of increasing the number of NF-κB binding
sites for a highly sensitive reporter expression induction. Indeed, the
intensity of the response to proinflammatory cytokines correlates to the
number of kB sequences in the enhancer/promoter sequence (Matsuda
et al., 2007). Our bidirectional expression cassette is predicted to
contain 22 NF-κB binding sites (Figure 22 A). This number of NF-κB
binding sites is almost 3 times the number of NF-κB binding sites
present in the currently available zebrafish NF-κB reporter vector (Kuri et
al., 2017). Despite this improvement, the bidirectional
enhancer/promoter length is only 1.2 kb.
This reporter line may be used in several zebrafish inflammation or
tissue regeneration models. Additionally to its role as reporter, this
enhancer/promoter system can be used for therapeutic approaches, as
already proposed (Chtarto et al., 2013), or preferably combined to the
ER intrabody knockdown technology to study the role of certain surface
or secreted molecules specifically during the processes of tissue
regeneration or host infection. Using purely CpG-free expression
systems we indirectly contributed to expand the portfolio of
enhancer/promoter combinations suitable for non-viral gene therapies
approaches, already in clinical trials for the treatment of cystic fibrosis
(Alton et al., 2015).
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These vector needs to be CpG-free as the presence of even only one
CG in bacteria derived plasmid DNA was proven to induce inflammatory
responses in mammal lungs proportionally to the number of CGs in the
sequence and the pDNA amount (Lindberg et al., 2015).
In the future, the broad availability of different tissue-specific zebrafish
enhancers and inducible expression systems will allow for the
generation of ER intrabody fish lines where protein knockdown can be
finely regulated at spatial and temporal level. This approach would
facilitate to use zebrafish to model human diseases which are
associated to particular protein activity dysregulation in specific tissues
and developmental stages.
Conclusions and Outlook
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5. Conclusions and Outlook
After the recent successful demonstration of ER mediated intrabody
knockdown in living transgenic mice (Marschall et al., 2014), this study
demonstrated that the same protein-level knockdown technology can
also be employed in the important zebrafish model. In this model, only
cytosolic genes were knocked down at the protein level so far (Gross et
al., 2016), but not yet those expressed through the secretory pathway.
While the proof of principle clearly demonstrated compatibility with the
zebrafish physiology, it became evident that vector design for ubiquitous
gene expression in vivo zebrafish - necessary to phenocopy null mutant
phenotypes - is not trivial in this context and will need more attention in
future applications. However, this question can be systematically
assessed experimentally given the ease of zebrafish genetic
manipulation and available transgenic lines, thus promising to bypass
the in vivo mouse transgenic system for ER intrabodies in speed and
versatility in the near future. Further, the lack of immortalized, fast
proliferating zebrafish cell lines, more easy to cultivate and transfect,
constituted a practical limitation to the screen of ER intrabodies. These
restrictions were substantially overcome by methodological
improvements achieved in this study on the way, like progress in
electroporation of zebrafish cells (Sassen et al., 2017; Russo et al., 2018,
JoVE) or FACS protocols using primary cells (Russo et al., 2018, N
Biotechnol.), which will further facilitate these as well as general studies
of zebrafish. Overall this work contributed to enrich the portfolio of
protein-based methods for studying the gene function in zebrafish, a
model that lack alternatives to the well consolidated DNA and RNA
based knockout and knockdown techniques.
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6. Summary
In this study we present the generation of 11 novel sequence-defined
human scFv antibodies against zebrafish Cdh2 via phage display. We
further describe the process of antibody validation for highly specific
protein identification in different assays and for targeted protein
knockdown in vitro and in vivo in zebrafish.
Zebrafish is gaining popularity for being better suited than mice for
studying in vivo, in real time, and on larger sample numbers the
correlation between complex behavior and physiological activity at
single cell level in the presence of specific stimuli (Vladimirov et al.,
2018). Also thanks to its ease of genetic manipulation (Sassen and
Köster 2015), zebrafish has been already convincingly used to model
human diseases for fast HTP drug screenings (Griffin et al., 2017).
Nevertheless, in contrast to the constantly growing availability, in
quantity and quality, of tools and techniques for zebrafish in vivo studies
and genetic engineering, the zebrafish community is still limited by the
lack of well characterized antibodies against zebrafish proteins for
reliable protein localization studies and antibody-based methods for
protein knockdown. Aim of this work was to provide a case study that
shows how to obviate or compensate, at least in part, for these
limitations. We generated via phage display 11 novel sequence-defined
human scFv antibodies against zebrafish Cdh2. Three of these
antibodies were found to be cross-reactive with the human Cdh2 in
ELISA and flow cytometry on human cell lines. A thorough binding
profile characterization unveiled that two of the generated antibodies
were highly specific in both whole mount immunostaining, as well as in
flow cytometry on primary cells derived from 3 dpf larvae. In parallel,
these extensive specificity assessment proved that the only available
commercial antibody against zCdh2 identified as zCdh2+ cells that do
not express the antigenic target at all. This finding put under the spotlight
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at least six different published studies where this commercial antibody
was used to mark zcdh2-expressing tissues (Tuttle et al., 2014; Xing et
al., 2015; Han et al., 2016; Mochizuki et al., 2017; Gays et al., 2017;
Powell et al., 2018). Our sequence defined monoclonal antibodies here
may serve as better alternatives for Cdh2 detection in whole mounts,
FACS, and other assays. Indirectly, we validated two inexpensive, but
very robust approaches to characterize antibody specificity.
In a second phase of the project, we used the antibodies generated
against zCdh2 as tools for protein knockdown in vitro and in vivo.
Antibodies in the scFv format where genetically fused to the KDEL
peptide sequence DNA and expressed in living cells, or in vivo in
zebrafish, to mediate zCdh2 ER-retention and consequently its
functional knockdown. When expressed in vivo in atoh1a+ progenitors,
one of these ER intrabodies was shown to interfere with THN nuclei
primordia formation. A phenotype similar to the one already described
for granule cells originating from the same neuronal progenitors in
zCdh2 defective mutants (Rieger et al., 2009). This constituted the first
successful attempt to utilize the ER intrabody technology in zebrafish.
This knockdown approach, together with the use of cytosolic stable
antibodies/antibody-like molecules for protein activity interference
(Gross et al., 2016), constitute a significant expansion of the available
zebrafish tools for gene function studies and for modeling human
diseases in this organism model. Acting at protein level, these
knockdown approaches allow for better protein isoform discrimination
and also constitute a valuable alternative in gene function studies where
RNA and DNA based knock-down/-out methods generated controversial
results (Kok et al., 2015; Stojic et al., 2018). Overall, we proved that
protein based approaches can have a beneficial impact on the zebrafish
community, provided that the process of generation of these tools is
subjected to a extensive and thoughtful characterization processes.
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Ithaka
As you set out for Ithakahope the voyage is a long one,full of adventure, full of discovery.Laistrygonians and Cyclops,angry Poseidon—don’t be afraid of them:you’ll never find things like that on your wayas long as you keep your thoughts raised high,as long as a rare excitementstirs your spirit and your body.Laistrygonians and Cyclops,wild Poseidon—you won’t encounter themunless you bring them along inside your soul,unless your soul sets them up in front of you.
Hope the voyage is a long one.May there be many a summer morning when,with what pleasure, what joy,you come into harbors seen for the first time;may you stop at Phoenician trading stationsto buy fine things,mother of pearl and coral, amber and ebony,sensual perfume of every kind—as many sensual perfumes as you can;and may you visit many Egyptian citiesto gather stores of knowledge from their scholars.
Keep Ithaka always in your mind.Arriving there is what you are destined for.But do not hurry the journey at all.Better if it lasts for years,so you are old by the time you reach the island,wealthy with all you have gained on the way,not expecting Ithaka to make you rich.
Ithaka gave you the marvelous journey.Without her you would not have set out.She has nothing left to give you now.
And if you find her poor, Ithaka won’t have fooled you.Wise as you will have become, so full of experience,you will have understood by then what these Ithakas mean.
Constantine P. Cavafy, 1911(Translated by Edmund Keeley & Philip Sherrard)
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